CN107287236B - Construction method of mouse model for human acute pancreatitis - Google Patents

Construction method of mouse model for human acute pancreatitis Download PDF

Info

Publication number
CN107287236B
CN107287236B CN201710553062.9A CN201710553062A CN107287236B CN 107287236 B CN107287236 B CN 107287236B CN 201710553062 A CN201710553062 A CN 201710553062A CN 107287236 B CN107287236 B CN 107287236B
Authority
CN
China
Prior art keywords
mouse
prss1
gene
mice
pancreatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710553062.9A
Other languages
Chinese (zh)
Other versions
CN107287236A (en
Inventor
张国伟
周杰
阚和平
钱建平
林振宇
任昰婧
范宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southern Hospital Southern Medical University
Original Assignee
Southern Hospital Southern Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Hospital Southern Medical University filed Critical Southern Hospital Southern Medical University
Priority to CN201710553062.9A priority Critical patent/CN107287236B/en
Publication of CN107287236A publication Critical patent/CN107287236A/en
Application granted granted Critical
Publication of CN107287236B publication Critical patent/CN107287236B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278Knock-in vertebrates, e.g. humanised vertebrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877Techniques for producing new mammalian cloned embryos
    • C12N15/8775Murine embryos
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6427Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21004Trypsin (3.4.21.4)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/035Animal model for multifactorial diseases
    • A01K2267/0368Animal model for inflammation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a method for constructing a mouse model of human acute pancreatitis. Constructing a targeting vector plasmid containing PRSS1 gene, and electrically transferring the targeting vector plasmid containing PRSS1 gene into mouse embryonic stem cells to obtain the mouse embryonic stem cells carrying recombinant PRSS1 gene; microinjecting the mouse embryonic stem cells carrying the recombinant PRSSS1 gene into albino mouse blastocyst, transferring the injected blastocyst into a pseudopregnant female mouse uterus for future birth, and obtaining a chimeric mouse after transplantation; the male chimera mouse with the chimera rate of more than 50% is combined with wild C57BL/6J female mouse to breed the next generation mouse, and the mouse carrying PRSS1 gene is selected. The phenotype of the model mouse is very consistent with the pathogenesis process of human pancreatitis, so that a specific animal model which completely imitates human pancreatitis from gene to phenotype is obtained, and the model can be further widely used for researches on pathogenic causes, pathological mechanisms and the like of human PRSS1, and screening of pancreatitis treatment medicines, gene treatment experiments and the like.

Description

Construction method of mouse model for human acute pancreatitis
The technical field is as follows:
the invention belongs to the field of animal model construction, and particularly relates to a construction method of a mouse model for human acute pancreatitis.
Background art:
acute Pancreatitis (AP) is a clinically common and potentially fatal risk of acute abdomen. Despite the great progress made in the diagnosis and treatment of AP, the mortality rate is still around 10%, and the rate of severe cases reaches 50%. The most important reason is that the specific mechanism of initialization of AP is not fully understood, and there is no way to guide the development of new, more effective drugs for the treatment of pancreatitis. Over the last 20 years, a number of studies based on experimental animal models of pancreatitis have found that premature activation of trypsinogen (trypsingen) within acinar cells plays a critical role in the process of AP initialization. However, the specific mechanism of trypsingen activation and its role in the development of pancreatitis have not been clearly explained. The important reason for the lack of research delay in the field of pancreatitis at present is that: there is a lack of ideal experimental animal models to perform in vivo experiments.
At present, several animal models of experimental acute pancreatitis are widely used, including methods of ranophanin injection, pancreatic duct ligation, bile salt pancreatic duct retrograde perfusion, ethylene thiochloric acid diet, arginine injection, and the like. These animal models have largely deepened our understanding of the mechanism of acinar injury in the early stage of acute pancreatitis. However, these animal models often produce non-specific manifestations in the course of inducing pancreatitis, rather than specific activation for trypsinogen. And over 70 clinical trials over the past 40 years have found no clear experimental evidence: inhibition of Trypsin (produced by trypsinen activation) activation may improve the pathogenesis of pancreatitis. The greatest possibility of inconsistency between clinical and animal experimental results is that the existing animal models are not suitable for researching the action of activation of the endoplasminogen in the initial pathogenesis stage of pancreatitis and detecting the action of potential drugs on treatment and protection of pancreatitis. Therefore, the novel animal model needs to be constructed to research the action of trypsin in the initial process of pancreatitis, and transgenic animals bring possibility for basic research and development of new drugs.
Saluja et al established a transgenic mouse in which a trypsingen heterobody expression gene (a mouse gene) was knocked out by a gene knock-out method, and conducted preliminary studies. Unlike the traditional view, they consider: activation of trypsinogen within the acinus results in necrosis of the AP early acinus, and these lesions account for 50% of the AP lesions. However, local and systemic inflammatory responses of AP, as well as the progression of chronic pancreatitis, do not require activation of trypsingen.
Figure BDA0001344961570000011
N et al generated transgenic mice expressing the human wild-type PRSS1 gene and they considered: expression of the PRSS1 gene promotes apoptosis of mouse acinar cells and can contribute to the development of spontaneous pancreatitis. The two experimental conclusions described above are partly contradictory, and the reason for this analysis is that the transgenic mice used have defects: the promoters used for expressing the target genes are all elastase of rat origin, but not elastase of human origin, so the credibility of the experimental results is basically questioned. In addition to the targeted expression of the human cationic trypsinogen gene in pancreatic acinar cells, the ideal AP transgenic animal model must use human elastase as a promoter.
The invention content is as follows:
the invention aims to provide a method for constructing a human acute pancreatitis mouse model, the human acute pancreatitis mouse model constructed by the method accords with the positioning expression of human cationic trypsinogen genes in pancreatic acinar cells, simultaneously human elastase is used as a promoter, and the phenotype of the human cationic trypsinogen gene is very similar to the pathogenesis process of human acute pancreatitis, so the human acute pancreatitis mouse model is a very good disease model of human acute pancreatitis.
The method for constructing the mouse model of the human acute pancreatitis is characterized by comprising the following steps of:
constructing a targeting vector plasmid containing PRSS1 gene (human cationic trypsin protogene), and electrically transferring the targeting vector plasmid containing PRSS1 gene into mouse embryonic stem cells to obtain the mouse embryonic stem cells carrying the recombinant PRSS1 gene; microinjecting the mouse embryonic stem cells carrying the recombinant PRSSS1 gene into albino mouse blastocyst, transferring the injected blastocyst into a pseudopregnant female mouse uterus for future birth, and obtaining a chimeric mouse after transplantation; the male chimera mouse with the chimerism rate of more than 50 percent and a wild C57BL/6J female mouse are combined into a cage, a next generation mouse is generated through propagation, and a mouse carrying PRSS1 gene is screened, namely the mouse model simulating the human acute pancreatitis.
The nucleotide sequence of the targeting vector plasmid containing PRSS1 gene (human cationic trypsin gene) is preferably shown in SEQ ID NO. 1.
Furthermore, the construction method of the targeting vector plasmid containing PRSS1 gene (human cationic trypsin gene, GenBank Accession Number: NM-002769.4) is as follows:
using PRSS1-BAC plasmid as a template, carrying out PCR amplification under the action of primers PCR1F and PCR1R, PCR2F and PCR2R, and PCR3F and PCR3R to respectively obtain an amplification product PRSS1-PCR1, an amplification product PRSS1-PCR2 and an amplification product PRSS1-PCR 3; PRSS1-PCR1 and a vector PL253 are connected to form a plasmid PRSS1-PCR1-PL253, an amplification product PRSS1-PCR2 and a plasmid PRSS1-PCR1-PL253 are connected after double enzyme digestion to form a plasmid PRSS1-PCR1-PCR2-PL253, and then the amplification product PRSS1-PCR3 and a plasmid PRSS1-PCR1-PCR2-PL253 are connected after double enzyme digestion to form a plasmid PRSS1-PCR1-PCR2-PCR3-PL 253.
The method for constructing the mouse embryonic stem cell carrying the recombinant PRSS1 gene comprises the following steps:
(1) treating the targeting vector plasmid containing PRSS1 gene with NotI to linearize it and regulate the DNA concentration of the plasmid vector to about 1-5. mu.g/. mu.l;
(2) preparation of fertilized eggs: female C57BL/6J mice were screened for 3-4 weeks and injected with pregnant horse serum (PMSG) and chorionic gonadotropin (hcg) separately, with a time interval of 46-48 h. After HCG injection, female mice were mated with adult fertile adult male mice to fertilize the female mice. After euthanizing the female rat the next day, collecting fertilized eggs from the oviduct, and culturing in an incubator for later use.
(3) Prokaryotic microinjection: microinjection injection needles and fixing needles were prepared. The linearized and purified targeting vector plasmid containing PRSS1 gene was diluted to 1-5ng/ul injection solution, which was loaded into a microinjection needle. And screening fertilized eggs with normal shapes, and placing the fertilized eggs in an injection dish for microinjection. Under an inverted microscope of 200-fold and 400-fold, an exogenous DNA solution (injection) is injected into the nucleus of a fertilized egg cell by means of microinjection. Transferring the injected fertilized eggs into an incubator, and transplanting after culturing for 1 h; or cultured to 2 cells for transplantation the next day.
(4) Preparing a surrogate mouse and transplanting an embryo:
preparing a pseudopregnant mother mouse: and (3) mating fertile male mice with proper age with the sterilized male mice after the spermaduct ligation, and stimulating female mice to generate a series of pregnancy changes to obtain pseudopregnant female mice which are used as surrogate pregnant mice after the fertilized eggs are transgenic. The fertilized egg injected with the exogenous gene is transplanted into the egg duct of the surrogate mother mouse on the day of the insertion. And (4) putting the surrogate mother mouse into a clean cage box, preserving heat, and putting the surrogate mother mouse back to the cage for breeding after the surrogate mother mouse is clear. After successful oviduct transplantation, the female mouse will normally farrow 19-20 days after the operation. After the mouse is born for 1 week, the mouse can be subjected to paw shearing numbering and PCR identification; mice were housed independently 3 weeks after birth in cages.
(5) Identification of born F0 mice: collecting 1-2 weeks old young mouse tissue (tail or toe tissue), lysing the tissue and extracting genome. And carrying out PCR amplification and electrophoresis detection by using a specific primer aiming at the target gene, and screening out the offspring integrated with the exogenous gene. The mouse with integration is called the first building mouse (fountain), can be passaged and established, and needs to be identified by the protein expression level.
(6) Passage and establishment of transgenic mouse, mating and passage of mouse with exogenous gene and mouse without transgene; each first-established mouse needs to be passaged independently. The F1 mouse was born and was identified as F0 that was normally germline transmitted, with a 50% probability of the progeny carrying the gene of interest integrated. The resulting F1 positive mice can be used for experiments and continued passaging. If homozygotes are to be obtained, the positive F1, which may be of the same origin, is mated siblings, and the F2 mice are born with a 25% probability of being homozygotes. And (4) establishing stable passage of the screened mice with the expressed target genes, and recording the passage condition and the pedigree. This resulted in a PRSS1 knock-in mouse, a mouse model of human acute pancreatitis.
Phenotypic identification of PRSS1 knock-in mice: the PRSS1 gene constructed by the invention can show the expression of acute pancreatitis after being knocked into a mouse (12-16 weeks) and injected with ranulin for 24 hours; chronic pancreatitis can be manifested after repeated injections of ranolanin for 4 weeks. So far, no information about the knock-in mouse of the wild type PRSS1 gene is found in domestic and foreign literature reports, patent databases and animal model catalogues including the Jackson institute of the largest mouse resource center in the world. Therefore, the mouse model can be widely used for researching pathogenic causes, pathological mechanisms and the like of the acute pancreatitis and the chronic pancreatitis of the human body.
The invention has the beneficial effects that: the invention utilizes gene targeting technology to generate and screen the first international PRSS1 gene knock-in mouse strain. The phenotype of the model mouse is very consistent with the pathogenesis process of human pancreatitis, so that a specific animal model which completely imitates human pancreatitis from gene to phenotype is obtained, and the model can be further widely used for researches on pathogenic causes, pathological mechanisms and the like of human PRSS1, and screening of pancreatitis treatment medicines, gene treatment experiments and the like.
Description of the drawings:
FIG. 1 is a schematic diagram of the construction of a targeting vector plasmid containing PRSS1 gene.
FIG. 2 is an electrophoretogram of the amplification products of primers F2/R2 and F3/R3.
FIG. 3 is an electrophoretogram of the cleavage products of the enzyme DraIII and the enzyme NruI.
FIG. 4 is an electrophoretogram of the cleavage product of the enzyme Bg 1I.
FIG. 5 shows the results of PCR identification of PRSS1 transgene in PRSS1 knock-in mice (primers F1 and R1), PRSS1 knock-in mice 10, Marker M, positive control, WT wild type mice, and water 10.
FIG. 6 shows the results of PCR identification of PRSS1 transgene in PRSS1 knock-in mice (primers F2 and R2), PRSS1 knock-in mice 10, Marker M, positive control, WT wild type, and water 10.
FIG. 7 shows the results of PCR identification of PRSS1 transgene in PRSS1 knock-in mice (primers F3 and R3), PRSS1 knock-in mice 10, Marker M, positive control, WT wild type, and water 10.
FIG. 8 shows the results of PCR identification of PRSS1 transgene in PRSS1 knock-in mice (primers F4 and R4), PRSS1 knock-in mice 10, Marker M, positive control, WT wild type, and water 10.
FIG. 9 shows the results of PCR identification of PRSS1 transgene in PRSS1 knock-in mice (primers F5 and R5), PRSS1 knock-in mice 10, Marker M, positive control, WT wild type, and water 10.
FIG. 10 shows the expression of PRSS1 protein in pancreatic tissue of mice knocked in the PRSS1 gene. In Wild Type (WT) mice, PRSS1 is hardly expressed, while the expression level of PRSS1 protein in PRSS1 knock-in mice accounts for almost 50% of that of normal people, which shows that the transgenic mice are comparable to people and can be used for simulating the pathogenesis of acute pancreatitis of people.
FIG. 11 is a photograph showing the phenotype of Acute Pancreatitis (AP) induced by injecting ranulin (cerulein) into PRSS1 knock-in mice (24 hours later) and the HE staining of pancreatic tissue. Compared with wild type mice, the PRSS1 gene knock-in mice have obvious pancreatic tissue edema with inflammatory cell infiltration after cerulein injection.
FIG. 12 is a graph showing that pancreatic amylase, tissue score, degree of tissue edema, and Trypsin activity were significantly increased 24h after the injection of ranolanin into PRSS1 knock-in mice, compared to wild-type mice. The PRSS1 can well simulate the pathogenesis of the human acute pancreatitis.
FIG. 13 shows that the activity of Microsome enzyme was significantly increased after repeated injections of ranulin (cerulein) into PRSS1 knock-in mice (after 40 min), while the activity of Zymogen and Lysome was not significantly changed. None of these changes were significantly altered in wild type mice.
FIG. 14 is a photograph showing the phenotype of Chronic Pancreatitis (CP) induced by repeated injections of ranulin (cerulein) into PRSS1 knock-in mice (after 4 weeks), and staining of HE and Mason in pancreatic tissues. PRSS1 mice can also well simulate the pathogenesis of chronic pancreatitis, i.e., acute pancreatitis with repeated attacks can be evolved into chronic pancreatitis.
FIG. 15 is a comparison of the markers associated with chronic pancreatitis in wild-type mice and PRSS1 knock-in mice. It is evident that PRSS1 mice showed significant changes in pancreatic specific gravity, tissue score, and blood glucose after the injection of ranophanin.
The specific implementation mode is as follows:
the following examples are further illustrative of the present invention and are not intended to be limiting thereof.
Breeding and breeding of mice: c57BL/6J was purchased from Jackson laboratories (USA) and maintained in the SPF-rated animal house of the southern Hospital animal institute of southern medical university. All mouse manipulations were approved and supervised by the southern university of medical institute animal care committee.
Example 1 construction of targeting vector plasmid containing PRSS1 Gene
Firstly, constructing a vector: the schematic construction is shown in FIG. 1.
1. Constructing an intermediate vector, and constructing a target fragment into a pStart-K framework;
2. amplifying a fragment to be recombined;
3. carrying out homologous recombination on the amplified fragment and BAC;
4. screening correct clones;
5. amplifying the target fragment on the BAC and sending the amplified target fragment to a detection device;
6. the correctly sequenced BACs were subjected to cycle sequencing.
7. And verifying the correctness of the obtained carrier.
8. The carrier plasmid (namely the targeting carrier plasmid containing PRSS1 gene, the nucleotide sequence of which is shown in SEQ ID NO. 1) is transformed into escherichia coli to obtain the escherichia coli liquid transformed with the carrier plasmid.
II, plasmid preparation
1. Plate-streaking the bacterial solution, and picking out the monoclonal
Carrying out plate streaking on the escherichia coli liquid transformed with the vector plasmid in the step one, and then randomly selecting 8 clones for PCR verification
The primers used were:
F2:GGAAGACTGATTTTTGCATATCATG
R2:GGTTCTTTAATCTAACATATCCCCT
the amplification product was 314 bp.
F3:AGCACATAGAGACAAAATATGC
R3:GGTCATCAGTATATCGAACTATTCT
The amplification product is 364 bp.
If both amplification products were amplified, the clone was a positive clone, designated E.coli harboring a targeting vector plasmid containing the PRSS1 gene. The electrophoretogram of the PCR product is shown in FIG. 2.
2. Selecting one from the positive clones for shake culture
Escherichia coli carrying the plasmid containing PRSS1 gene as a targeting vector was inoculated into 100mL of LB medium supplemented with antibiotics, and cultured in a shaking incubator (Shanghai Zhichu apparatus Co., Ltd., product number: ZQLY-300S) at 37 ℃ at 225rpm/min for 16 hours.
3. Plasmid extraction
After the time for shaking the bacteria, plasmid extraction was performed with QIAGEN plasmid DNA purification kit (QIAGEN corporation, Shanghai, Inc., Cat. No.: 12145) to obtain plasmid, the specific method was as follows:
a) the overnight LB-cultured bacteria were harvested and centrifuged at 6000g at 4 ℃ for 15 min.
b) 10ml Buffer P1 was added to resuspend the bacteria.
c) Adding 10ml Buffer P2, shaking the centrifuge tube 4-6 times to mix thoroughly, and standing at room temperature for 5 min. If Lyseblue reagent is used, the solution should become uniformly blue.
d) During incubation, the seal of the needle opening is opened and the filter is placed on the appropriate rack.
e) Add 10ml of ice bath Buffer P3 to the lysate and mix it by vigorously shaking the tube 4-6 times. If Lyseblue reagent is added, mix the reagents until there is no color.
f) The lysate was poured into a filter sealed at the needle and left at room temperature for 10min without the insertion of a piston. The needle seal was opened and the piston gently squeezed to filter the lysate into a new 50ml centrifuge tube.
g) 2.5ml Buffer ER was added to the filtered lysate, mixed well 10 times and incubated on ice for 30 min.
h) A column of QIAGEN-tip 500 was hung from another centrifuge tube, 10ml of Buffer QBT was added, and the solution in the tube was emptied by gravity drip.
i) The lysate incubated on ice from step 7 was added to a QIAGEN-tip column and allowed to slowly drip through the resin.
j)10 the QIAGEN-tip column was washed with 2X 30ml Buffer QC.
k)11 DNA was eluted with 15ml Buffer QN and the DNA eluate was collected in a centrifuge tube.
l)12 Add 10.5ml of isopropanol to the eluate to precipitate the DNA and mix well. Greater than 15000 Xg, centrifuged at 4 ℃ for 30min and carefully decanted supernatant after centrifugation.
m)13 washing of DNA with 5ml endotoxin free-70% ethanol (40 ml 96% -100% ethanol added to endotoxin free water in the kit), 15000g, centrifugation at 4 ℃ for 10 min. Carefully pour out the supernatant without encountering the plasmid.
n)14 drying the plasmid at the bottom of the centrifuge tube for 5-10 min. The DNA was re-solubilized using an appropriate volume of Buffer PA.
o)15 the concentration of the DNA plasmid was determined and recorded.
4. Detection of plasmids
Carrying out enzyme digestion verification on the plasmid extracted in the step 3, wherein the enzyme digestion time is 1h
Enzyme digestion system: 20uL
DNA 500ng
Buffer 2uL
Enzyme (DraIII or NruI) 1uL
Replenishing water to 20uL
The enzyme digestion scheme is as follows:
DraIII 12.514/9.181/6.336/3.557/3.132/1.740 (Kbp)
NruI 36.460 (Kbp)
the electrophoretogram of the cleavage product is shown in FIG. 3. Thus obtaining the targeting vector plasmid containing the PRSS1 gene, and the nucleotide sequence is shown as SEQ ID NO.1 after sequencing.
5. Linearization of plasmids
The targeting vector plasmid containing the PRSS1 gene is subjected to linear enzyme digestion, and an enzyme digestion system
DNA 30ug
Enzyme (NruI) 70U
Buffer 25uL
Replenishing water to 250uL
The enzyme digestion time is 16h at 37 DEG C
Restriction enzyme cleavage scheme NruI 36.460Kbp
This gave a linearized targeting vector plasmid containing the PRSS1 gene.
6. Recovery of DNA fragment (linearized targeting vector plasmid containing PRSS1 Gene)
The linearized targeting vector plasmid reaction solution containing the PRSS1 gene of step 5 was recovered in agarose Gel using the QIAquick Gel Extraction Kit (250) with the cat No. 28706 by the following method:
a) a fragment containing DNA of about 36.460Kbp in size was carefully excised under an ultraviolet lamp. And the excess gel was removed as much as possible.
b) Weighing the empty centrifuge tube, cutting off the gel with the target fragment, loading in a 1.5ml centrifuge tube, weighing, determining the weight of the gel block, determining the volume approximately, adding 700. mu.l Buffer QG, and incubating at 50 deg.C for 10 min.
c) After 10min, the gel block is completely dissolved, and the color of the mixed solution is closely observed whether the mixed solution is yellow or not, if the mixed solution is yellow, the next operation is continued.
d) To the mixed solution was added 230. mu.l of isopropyl alcohol and mixed well.
e) QIAquick spin columns (QIAquick spin columns) were packed in a clean 2ml collection tube.
f) The resulting solution from (c) was placed in a QIAquick adsorption column and centrifuged at 13,000rpm for 1 min. The waste was discarded and the QIAquick spin column was replaced in a 2ml collection tube.
g) 0.5ml of Buffer QG was added to the column and centrifuged at 13,000rpm for 1 min.
h) The column was mounted on a clean 1.5ml centrifuge tube, 50. mu.l of eluent or sterile water column membrane was added and centrifuged at 10,000 Xg for 1min, the solution in the centrifuge tube being the purified recovered DNA product and stored at-20 ℃ for use in enzyme applications. 0.75ml of Buffer PE was added again to the spin column and centrifuged at 13,000rpm for 1 min.
i) The liquid was discarded and centrifuged again at 13,000rpm for 1 min.
j) The column was removed and placed in a clean 1.5ml microcentrifuge tube.
k) Mu.l Buffer EB (10mM Tris. Cl, pH 8.5) was added to the middle of the adsorption column, left in the greenhouse for 1min, centrifuged again at 13,000rpm for 1min, and the supernatant was collected and stored at-20 ℃ for further use. This gave a linearized targeting vector plasmid containing the PRSS1 gene.
7. Identification of recovered fragments
The above-mentioned recovered fragment (linearized targeting vector plasmid containing PRSS1 gene) was subjected to enzyme digestion and identified,
enzyme digestion system: 20uL
DNA 500ng
Buffer 2uL
Enzyme 1uL
Replenishing water to 20uL
The enzyme digestion scheme is as follows: BglI 11/10/6.4/5/3.2/0.8
The electrophoretogram of the cleavage product is shown in FIG. 4, whereby a linearized targeting vector plasmid containing PRSS1 gene was obtained.
8. Delivery downstream
After the detection is finished, the linearized targeting vector plasmid containing the PRSS1 gene is labeled and distributed to downstream for injection.
Secondly, preparation of fertilized ovum
1. Preparation of fertilized eggs: c57BL/6 female mice were screened for 3-4 weeks and injected with Pregnant Mare Serum (PMSG) and chorionic gonadotropin (hcg) separately, with a time interval of 46-48 h.
2. After HCG injection, female mice were mated with adult fertile adult male mice to fertilize the female mice.
3. After euthanizing female mice with carbon dioxide at 9 am the next day, a fertilized egg culture dish (2 ml of M2 (reagent manufacturer SIGMA) culture medium was placed in a 37-degree preheating table and preheated for half an hour) was prepared, the mouse ovaries were taken out and placed in the preheated culture dish, 60 μ l of hyaluronic acid (reagent manufacturer SIGMA) was added, the fertilized eggs were collected from the oviduct, and the fertilized eggs were taken out and placed in a (balanced 12-hour M16 (reagent manufacturer SIGMA) culture dish) C02 incubator for culture and standby.
Third, pronucleus microinjection
1. Microinjection injection needles and fixing needles were prepared.
2. The linearized and purified plasmid (linearized targeting vector plasmid containing PRSS1 gene) was diluted to 1-5ng/ul of injection solution, which was loaded into a microneedle using a sample loader.
3. Selecting normal fertilized eggs, making M2 injection drops, placing the selected fertilized eggs into the injection drops, covering with paraffin oil (SIGMA, reagent manufacturer), and placing under a microscope for injection.
4. Under an inverted microscope of 200-fold and 400-fold, an exogenous DNA solution (linearized targeting vector plasmid containing PRSS1 gene) is injected into the nucleus of a fertilized egg cell by microinjection. The gas for injection is nitrogen, and the gas pressure is adjusted to expand the nuclear region by about 2 to 3 times before injection.
5. After the injection is finished, the injection dish is moved into an incubator and is transplanted after being cultured for 1 h; or transferring the fertilized eggs to an M16 culture medium for culture to 2 cells, and transplanting the fertilized eggs on the next day.
Preparation of surrogate pregnant mouse and embryo transplantation
1. Preparing a pseudopregnant mother mouse: and (3) mating fertile male mice with proper age with the sterilized male mice after the spermaduct ligation, and stimulating female mice to generate a series of pregnancy changes to obtain pseudopregnant female mice which are used as surrogate pregnant mice after the fertilized eggs are transgenic.
2. Before transplantation, the surrogate mouse is numbed by using an anesthetic (abdominal cavity injection is carried out by testing proper anesthetic dosage every time), then a port of 1cm is opened on the right back, an alcohol cotton ball is used for wiping the opening part before opening, the experimental equipment scissors and tweezers with high temperature and high pressure sterilization are used for pulling out the oviduct and exposing the oviduct in the visual field, the fertilized ovum injected with the exogenous gene (linearized targeting vector plasmid containing PRSS1 gene) is transplanted into the oviduct, and stainless steel wound clips are used for suturing.
3. And (4) putting the surrogate mother mouse into a clean cage box, preserving heat, and putting the surrogate mother mouse back to the cage for breeding after the surrogate mother mouse is clear. The following day, the mice subjected to the test were observed for abnormalities.
4. After successful oviduct transplantation, the female mouse will normally farrow 19-20 days after the operation.
5. After the mouse is born for 1 week, the mouse can be subjected to paw shearing numbering and PCR identification; mice were housed independently 3 weeks after birth in cages.
Fifth, mouse identification
1: collected tissues (tail or toe tissues) of 1-2 weeks old pups were lysed and genomes were extracted.
2. PCR amplification and electrophoresis detection are carried out by using specific primers aiming at the target gene (PRSS1 gene), and offspring integrated by the exogenous gene are screened out.
The primers used were as follows:
transgene PCR primer F1: GAGCGGATTTGAACGTTGTG
Transgene PCR primer R1: TACTTGAAGAGATTTGGCGG
Internal control PCR primer (control primer) F: CTATCAGGGATACTCCTCTTTGCC
Internal control PCR primer R: GATACAGGAATGACAAGCTCATGGT
Annealing temp. 60 deg.C
Expected PCR product (Expected product):
transgene PCR product size 356bp
Internal control PCR product size 507bp
Transgene PCR primer F2: GGAAGACTGATTTTTGCATATCATG
Transgene PCR primer R2: GGTTCTTTAATCTAACATATCCCCT
Internal control PCR primer (control primer) F: CTATCAGGGATACTCCTCTTTGCC
Internal control PCR primer R: GATACAGGAATGACAAGCTCATGGT
Annealing temp. 60 deg.C
Expected PCR product (Expected product):
transgene PCR product size 314bp
Internal control PCR product size 507bp
Transgene PCR primer F3: AGCACATAGAGACAAAATATGC
Transgene PCR primer R3: GGTCATCAGTATATCGAACTATTCT
Internal control PCR primer (control primer) F: CTATCAGGGATACTCCTCTTTGCC
Internal control PCR primer R: GATACAGGAATGACAAGCTCATGGT
Annealing temp. 60 deg.C
Expected PCR product (Expected product):
transgene PCR product size 364bp
Internal control PCR product size 507bp
Transgene PCR primer F4: GGTGATGGCTGTGCCCAGAA
Transgene PCR primer R4: CCCCTTTCTCCCAAGCTTCT
Internal control PCR primer (control primer) F: CTATCAGGGATACTCCTCTTTGCC
Internal control PCR primer R: GATACAGGAATGACAAGCTCATGGT
Annealing temp. 60 deg.C
Expected PCR product (Expected product):
transgene PCR product size 339bp
Internal control PCR product size 507bp
Transgene PCR primer F5: TGCTGGCACCAAGTTCCTCATCTC
Transgene PCR primer R5: GCAAGAGATTACGCGCAGACCAA
Internal control PCR primer (control primer) F: GCAGAAGAGGACAGATACATTCAT
Internal control PCR primer R: CCTACTGAAGAATCTATCCCACAG
Annealing temp. 60 deg.C
Expected PCR product (Expected product):
transgene PCR product size 398bp
689bp of Internal control PCR product size
The electrophoretograms of the amplified products obtained by the five PCR primers are shown in FIGS. 5 to 9, and it can be seen from the above that the mice, which can amplify the desired fragment by the five PCR primers, are offspring integrated with PRSS1 gene. The mouse with integration is called the first building mouse (fountain), can be passaged and established, and needs to be identified by the protein expression level.
Sixth, passage and establishment of transgenic mice:
mating and passaging a mouse (a first-built mouse) with an exogenous gene (PRSS1 gene) and a mouse which is not subjected to transgenosis; each first-established mouse needs to be passaged independently. The F1 mouse was born and identified (same as step five) as F0 that was normally germline transmitted, with 50% of its progeny carrying the integrated gene of interest. The resulting F1 positive mice can be used for experiments and continued passaging. If homozygotes are to be obtained, the positive F1, which may be of the same origin, is mated siblings, and the F2 mice are born with a 25% probability of being homozygotes. And (4) establishing stable passage of the screened mice with the expressed target genes, and recording the passage condition and the pedigree. This resulted in a PRSS1 knock-in mouse, a mouse model of human acute pancreatitis.
Seventhly, phenotypic identification of PRSS1 knock-in mice:
1. detecting the expression of PRSS1 protein in mouse model tissue of human acute pancreatitis. As shown in fig. 10, PRSS1 was hardly expressed in wild type (WT, control) mice, while PRSS1 knock-in mice (Transgene) PRSS1 protein expressed in an amount of almost 50% of that of normal humans (Human), indicating that the transgenic mice are comparable to humans and can be used to simulate the onset of Human acute pancreatitis.
2. As shown in fig. 11, fig. 11 is a graph showing that PRSS1 knock-in mice induced Acute Pancreatitis (AP) phenotype (after 24 h) after injection of ranulin (cerulein) and HE staining of pancreatic tissue. Compared with wild type mice, the PRSS1 mice injected with cerulein had significant pancreatic tissue edema with inflammatory cell infiltration.
3. FIG. 12 shows that pancreatic amylase, tissue score, degree of tissue edema, and Trypsin activity were significantly increased in PRSS1 gene knock-in mice 24h after the injection of ranulin (cerulein) compared to wild-type mice in PRSS1 gene knock-in mice 24h after the injection of ranulin. The PRSS1 can well simulate the pathogenesis of the human acute pancreatitis.
4. FIG. 13 shows that the activity of Microsome enzyme was significantly increased after repeated injections of ranulin (cerulein) into PRSS1 knock-in mice (after 40 min), while the activity of Zymogen and Lysome was not significantly changed. None of these changes were significantly altered in wild type mice.
5. FIG. 14 is a photograph showing the phenotype of Chronic Pancreatitis (CP) induced by repeated injections of ranulin (cerulein) into PRSS1 knock-in mice (after 4 weeks), and staining of HE and Mason in pancreatic tissues. The PRSS1 knock-in mouse can also well simulate the pathogenesis process of chronic pancreatitis, namely, repeatedly-occurred acute pancreatitis can be evolved into chronic pancreatitis.
6. FIG. 15 comparison of wild type mice with PRSS1 mice for chronic pancreatitis-associated markers. It is evident that PRSS1 mice showed significant changes in pancreatic specific gravity, tissue score, and blood glucose after the injection of ranophanin.
In conclusion, after the PRSS1 gene constructed by the invention is knocked into a mouse (12-16 weeks) and is injected with ranulin for 24 hours, the acute pancreatitis can be expressed; chronic pancreatitis can be manifested after repeated injections of ranolanin for 4 weeks. So far, no information about the knock-in mouse of the wild type PRSS1 gene is found in domestic and foreign literature reports, patent databases and animal model catalogues including the Jackson institute of the largest mouse resource center in the world. Therefore, the mouse model can be widely used for researching pathogenic causes, pathological mechanisms and the like of the acute pancreatitis and the chronic pancreatitis of the human body.
The PRSS1 mouse obtained by the invention can be widely used for research on pathogenic causes and pathological mechanisms of human acute pancreatitis, screening of acute pancreatitis treatment drugs, gene therapy tests and the like through phenotype verification.
In addition to the above embodiments, the present invention may have other embodiments. All technical solutions formed by adopting equivalent substitutions or equivalent transformations fall within the protection scope of the claims of the present invention.
Sequence listing
<110> southern hospital of southern medical university
<120> construction method of mouse model for human acute pancreatitis
<160>1
<210>1
<211>36500
<212>DNA
<213> Artificial sequence
<400>1
cgtcgacatg aagaattaac tctcaacacc tctccactgc ctttggcaca gaacaagtag 60
gtaactatac ccacagtagc ataataatat atttttattt gaagaaattg agcagcccct 120
gaaaagagac ttacaaatac tgatatttca gtgtccctta cgaaacaacc agttccccgc 180
caaatctctt caagtaaaat ctcctagcaa acaagtacca tccatattac caggctttca 240
gtcaggtttt tagtgcttta ctcttaaaaa tcaatataca atcaaagatc actagtatac 300
aaagtttcta acatagatag aaaggaaaag gatacagaca ttaaaagaaa gaagagaaaa 360
agaaaataaa aaacaagaaa cagaaaaagg aaatgaaatt aaataaatag tgggaacaaa 420
gaaaattgac tcaagcatat aaaataaaga aaaaaagtgg acttctaagt agtaatcatg 480
taaattcttg tttctatccc agacagatat aagaaacaca tcgtccttaa aacagaataa 540
gataaagggg agaaacttta agaaagtcaa aataaatttt taaaataaga gtcaaaagaa 600
aactcgatat aacatcccag aaaatagaac aaaaagttca agaagttaaa taacagaaaa 660
catgaaagaa aatataagtg acttgaaggg tgaacaaagg agagtcaact gtccaagaga 720
aactccagaa aaaagaaaaa aaaaattttt aattatcaga gaaattatac cctaaaaatt 780
agttcccaga aatgaaaaaa aattagcctc catattttaa aatgcctgct gttggctaat 840
taatgtcaga caactgaaat gaaggcatat cttcatgatt tcagaacact ggggattaaa 900
tgattctaaa ccacaaaaag acaaagaaaa tgttaaaaat caaaattata cttagagaaa 960
agtgataaat aaatgcaaaa gtggaatgac atcacatttc tacacagcaa cgctgaattc 1020
cagaaaaaaa ggtgcaagaa atatcaataa aattctgata gaaaatcatt ttaatcttag 1080
atttctctac taacccaata tatcaataaa atgcaaataa aaagacattt ttaataatgt 1140
taggatccaa aacatttacc tccatctcaa gctttcttag gaaattactg gctagtatgt 1200
ctcagcaaac tgagaaaaca aaccaaaaag aaaaaaaaaa tggggtccag gaaatagaaa 1260
ttctcattca gaataataag aaagaaaagt gccaggataa aagctgggca gtggaactaa 1320
ttagcaacta gcccagacta aagcagaggg actccagggt tgcattttca aatagtgcca 1380
aaacgtagac tatggatcta ttaaatgata catctgagta actcatccac aattttgtag 1440
tatcagtttg catggcctgt caaaaatcca gatccatcct ggagaaggtg atcccattaa 1500
aaagaatcca gattattcag caatatcaaa tataggtaga aaccaaaaga caaaaatctg 1560
ctgatttttc aaaccattaa aaagattgat gcagttctgg taatggcatc ataattctta 1620
taagacccac gctcccacaa ataacaaata taaactcagg acgaacattt ttaaagccta 1680
tcttaaggga cagcaaagca accaatagcc agtagaaact acagggaagt caacacttgg 1740
atgacaggta agttttctgt ttttgtagct ttttgctgga aagtagttcc cagtcaaata 1800
gaaacccatt aaaaagccag ctgtagagtt aggaaagaca tccaagaagg gaaagtccaa 1860
aaaagaacaa cccaatgttc tccatacaaa ctctgtttga atctctggtt gatgcctaaa 1920
ctatgcatgt gagaggaata ctggaatcag cagtgttaaa cctaacataa ctggatagag 1980
atttcagctg ttgccggcta taggaaacag aatttgaagt ataaatccaa ccaagttaaa 2040
tgcctgttaa aacaaaaatc caaccatcgt tagaaggata aaacaaaatc tagatatatt 2100
gttgacaatg tccaagatac aacgcaaaaa ttaccaggca tatgaagaaa agaaatcaca 2160
tgacctaatt tgaatgaaga ggccattagt ggatacaaac tttgagttta cctggatgct 2220
ggaattacta gactgaaatt taaagtagct attataatca tgtttaagga tataaaagaa 2280
aatgttctta taatgaataa aataggaacg tttataacaa taatgaaacc tattaaaaat 2340
aaatgaaaaa tttaaaattt aaactgcaat atttgaaaat taaataaaat ctcactaaac 2400
gaaatctcta gcagattaga gatgacggaa gaaagattca gaaacttgat gttatatcca 2460
tagaaattac aaaatctaga aaacaggaga aaaaatatga aaaaatagcc tcagtgatct 2520
ttagaaaaat atcaaaaggt acaaaatgtg tgaaattgga gtaaaagtga aagaagagga 2580
gatataaaaa agcatggata aaaaacaata tttttttaaa aaagcctaat taaaaagtat 2640
attgaaagac ataaaaagaa tttcagaaaa ataatttgta gaacacctac ctaggcacat 2700
cacagtcaaa ttgtccaaaa ctagaaaaga agacaaaatc ttcaaacagc cagagaaaaa 2760
tcatacatac caggaacaat gacatgaata atgataattt ttcattttaa aaaagtgaat 2820
accagaagag aagggaactg tagctttaaa gtgctacaag aaatataaaa agtcaaccca 2880
gaatttgata taaaatattc agctaaaaat taaaatacta cagtaaagtt atctgaatat 2940
aaataaaaat taaaatatcc attgacagta gaactacatg atagtaaatc gcaatggaat 3000
tctcttaggt aaaaaagaaa taataccagt tggaagcttg gattgtgagg aagaaatgaa 3060
gagcacaaga agtagtgaaa tgcagtcaga tatattacat atatcatatg taagactagc 3120
taaagtaaaa atttcatcat tgtattatag gatatataaa atatatataa tacagaatga 3180
cactaaaatc taaaggatgg aaataggaaa aacagatcta ttagatacaa atttcttata 3240
ttttaagtaa acttctacaa tatagtaagt agacaaatag ttttaaatgt atcattcttt 3300
attttccaga atagccctga aaatattaga ggtatagcaa aaagccaaca aataaaaatc 3360
aaaacagaat ctaaaaatat tattcaaata tttaaataga gtcaattcta ggagaaagtt 3420
tggtataata ttaaaaaatc aatcaatgta attcatcttg ttaacacatt tttaaaaatc 3480
tatttgatta tacgtacaga tagaaaaaac ttggtaaaat tccaaactca tttataataa 3540
aaacactcag aaaattaggt aaaaaaggga cttcttcaat ctaacaaagg cacctgaaaa 3600
aaaccaacag cttatgtcac acttaatgac agaaatatta aacgtcttcc catttttatt 3660
tcttaaatat taaacatgtt caagatcata aacaagtcaa taatgttcac ccttaccact 3720
tctattccat attgtactga tgcataaaga caagaaaaat actaaaaagc taggtatcaa 3780
aagataaaga aaaccttttt cagagatgaa aggactactt acatgcaaat attaaaagaa 3840
atctatatat taactactca aattagtaag ttcatacatt aatttattat tacaacatat 3900
aaaaattata ttttgtatac taatgataaa caattggata attgaatttt aaaacctgaa 3960
tttatattaa aaaacataaa atatttaaat ttagcaaaag acatgcaaga cttgtgtaca 4020
gaaaactaaa aacagttgct aaaggaaatg aaagacagtt ttaaaatata gaaatagaaa 4080
taatgtcctg ttgcagcctc tgcctcagga gtcccctgca gcctggaaca cctagcaaaa 4140
gaaatgcagg tgcagtgcca gggattggag ctggatcccc acaagtccta gaagcaaacc 4200
ttgtgagggg gccatctgtc tccccgaccc acctcagagc atgcctgtga acaagaaagt 4260
acgagagcca cacaagctgg gtgttagcct agctaccggc cgttactctt aagcgcatct 4320
actggatcac agcacaaact acaacactaa aattaccgtg ctaatatatg caggatgtga 4380
aaccaggtgc aagaattcac ccacatatgc ggattctgta cagagccctg gccctccgaa 4440
agcatccaga aatgaagcca actgaccaca ctcagcttac accacagtta agggaacacc 4500
aaccctacca gatgagaaag aatcagcaca agaactctgg caattcaaaa aaaccacagc 4560
atctccttac atccaaatgg gtcactagct ccctagaaat ggttcttaac cggtctgaaa 4620
tggctgaaat gacaaacaca aaattcagaa tctggataga aaggaagctc attgagattc 4680
agaagaaagt tgaaactcaa tccaaggaat ccaagtaacc cagtaaaatg atccaagaac 4740
tgaaagatga aatagccatt ttgagaaaga atcaaaataa acttctagag ctcaaaaatt 4800
tactacaaga atttaataat gcaataagaa gtattaacag cagaatacac caagctgagg 4860
aaagaatctc agagcttgaa gaccagttct ttgaatcaac ttagatgaaa ataaagaaaa 4920
aagaatttta aaaaatgaac aaaactggcc aggcacggtg gctcacacct gtaatcccag 4980
ccctttggga ggccaaggct ggtggatcac gagttcggga gatcgagacc atcctggcta 5040
acacggtgaa accccgtctc tattaagaat ataaaaaaat tagctgggca tggtggcggg 5100
cacctatagt cccagctact caggaggctg aggcaggaga atggcatgaa cctgggaggc 5160
ggagcttgca gtgagccgag atagtgccac tgcactccag cctgggtgac agagcgagac 5220
tccatctcaa aaaaaaaaaa aaaataagga aataagaaat atagggttat gtaaagatac 5280
caaatctatg cctcatcggc attcccaaaa taggagaaag agtaagcaat ttcaaaaata 5340
tatttgaaaa atatattttt caaaaatata aataatgcct aatataaata taaataatgc 5400
caaaaatcgc ctaatcttgc tagagaggtt gaaattcaat tccaagaaat acagagaacc 5460
ctggctagtt actatatgag acaactatcc ccaagacaca tagtcatcag attcaccaag 5520
gtcaaggtaa aataaaaaaa attctaaagg cagctagagt gaagggtcaa gtcacataca 5580
gaggaaaccc catcaggcta gccacagact tctcagcaga aaacttataa gccagaagag 5640
attgggagac tattttcagc atcctgaaaa aaattcaact aaaaatgtta tatcctgcca 5700
aactaagctt cataaatgaa ggagaaataa aatccttctt agacaagcaa atctgaggaa 5760
atttgtttta agtagaccat ccttacaaaa ggtccttaag gtagtgctaa atatggaatc 5820
taaagaacct gctgccataa aacacttgaa tgcatagccc acaggcacca caaagcaact 5880
acgctatcaa atttacataa caaccagcta acaacatggg tatgagatca aaatcacaca 5940
catcaatact aatcttgaat ataaatgggc taaacatctg cttaaaagac attgagtggc 6000
aaactagata aaaacacaag acccagccat cattgccttc aagagaccca tctcacatgt 6060
aacaacaccc acaggctcaa aacaaagaga ggggaaaata tctatcatgc aaatgaaaaa 6120
caaaaaagga caggagttgc tattcttata tcagataaaa caaacattaa acaatgaagg 6180
gcattactat aatgataaag agtacaatcc aacaagaaga actaacaatg ctaaatatat 6240
atgcatccaa cattagaaca cccatatcca taaaacaagc tcttcttggc ctatgtaaag 6300
atttaaacaa ccaaacaata atagtaggaa acttcaacac cctactgaca gtgttagaca 6360
gatcactggg cagaaaacta acaaagaaat gctgggctta aactcaacat ttaaccagtt 6420
gaaactaata gacaaataca gaacactcca cccaaaagga atgcttatac actgttggtg 6480
gaaacgtaaa ttagttcagg cactgaggaa agcagttgga gatttctcaa ataatttaaa 6540
acagagctac cattccacct agcaatccca ttattgaaga tatatccaaa ggaaactaga 6600
tcattatacc aaaatgcact catatgttca tcaccatgca attcacaata gcaaagacat 6660
ggaatcaacc gaggttccca tcaacgatgg attggatgaa gaaaacatat acaccatgga 6720
ataccacaca ggcctaaaaa agaatgaaat caagttgttt gcagcaacat aaatagagct 6780
gaaggccgta gtcctaagta aattaatgca ggaacagaaa accaaatact acatgttctc 6840
acttacaagt gggaactaaa cattgagcgc acatgaacac aaacatggga atgattgaca 6900
ctgagcacta ctcaagggga agagagaggg aggttgacac gggttgaaaa actacctatt 6960
gggtactatg ttcactatct gggtgcagta tacccgtgta acaaaccttc atatgtaccc 7020
cctgtatcta aaataaaagt gagaatttta aaaagactaa atatgttaaa accagtactc 7080
tctaaatttt atctacagtc attaaaatct caattgttat ctcaactgtt tttgttttct 7140
aagaaactga gaagctgatt ctagaaggta tatgaacaca caaagaattt atgggaagtc 7200
ccgctcctgg ttagaagcct atgtatgatg tttcaggcca tagataatta attacaaagg 7260
ctttacctgg ctggtttaca gggtgtggag aggctgttct gcccacccca gacttggtgc 7320
acagccaatg cattgcagtc tttgaaggga gttgcagtca aggaccccct ggctggtcac 7380
gcccttgtgc atatttatat tgccagctca ggatccttca ttcttaggtc tctttttctg 7440
aggcctatgt agaggtcttc ttcaggtgcc tctgtcaagg cctcctaata ggagaggaag 7500
agagagcctt aaagacactt ttctccactc tgagtaccca gtgagtttcc actttctcct 7560
tgcagggctc cccaacagtg agacaactcc atgtctgtgc taatccaact aacacttgac 7620
cagtgccatt tccacaggga aaaacagaac agggggagtc agtaatttct ctggctttag 7680
actcttgctt acactattga aggaggtaat taaagattta actctttcct ttggggcttg 7740
ttgctttaat tggctcacta cctggatgca atatacccat gtaacaaacc tgcatgtgta 7800
ccccctgtat ctaaataaaa gttgaaattt taaaaagaat aaatatgtta aaatgagtac 7860
ctaagtcctc agcactcttt ttcagctatg ctgagctcct gacactctag aatattcaaa 7920
acaatattta gaaagaacac atttggagtc ctttcactgt ctgaccaaga cttactataa 7980
acccacaata atcaaagtaa tgtggtactg gcaaaagggc agacaaataa aagatacaca 8040
ttaaaaccac aatgagatac cgctaaccat ccacataccc actcaagtta aaccacctgg 8100
caacaccaaa tgctggcaaa aatttggagt cccagaactc acatatattg ttgatgaaag 8160
tggataatag tacaaccaat gtggaaaatg ttctaatagt ttcttataaa actaaacccc 8220
tctgatcatc tacccctatg agccagcaat tatactccta agtatttact taagagaaat 8280
aaaggcataa atctacaaaa aaagacttaa actggaatgt ttacagaaag tgaattcatc 8340
attgccaaaa cctggagata tcttgaacgt ccatctacag gaggctggct aaacaaacgg 8400
tagtatatct atatggttac atattccact gccacaaaaa ggaatgaagt actgatacac 8460
acaacttgaa caaatcttaa aaatattatt ctgggtgaaa gaagtaaaca aatcttaaaa 8520
ccattattct gggtgaaaga aactttgcac agaagagcgt atgatgttat tccatttata 8580
taaaattcta gaaaagaata atttataatg aaaaaatcag aacactaatt gcctctaagg 8640
agttagcagt gggaaaaact aaaggcatga gaaaactttg gagataatgg taatattcta 8700
caatttggta ggttacacag tgtatgcatt tgtcaaaact tgtttaacgg tattcaagat 8760
ttgtgtgtgg tgctgtatgc aaattttacc tgaaaaacac cttgaactcc agttaattat 8820
acacgtgctg aactgcttag aagtgaagta tgcctccaac tgacttttca atgaattaaa 8880
aaattagatg gattgatgga tgaatagaag gatggataga tggatagtta tgtggtaaag 8940
cagtaacagt tttatccaga acctaggcgg tgggtacatg catgttcact gtataatagt 9000
ttcagcttct atagatgttt gaaaattctc ataataaaat ggaaaataat ggcatgattc 9060
tgtgtatttt ttaataaaat caactttgaa atatgctgat aagaaccaca ttgctaatta 9120
aagaagtgaa gtacaggaag gtttgggctg tgtgtttctg tgtaaaagaa ggaggagtca 9180
gatttacata aacttgaaca agcaagaact attatttcta agaacatgta gcaaaataat 9240
tacaagactg tctctggaga aggaacttac cttttgttct ctgttataat tgaatcatta 9300
accaggtgca tgtattaatt caataaataa acacattaaa attcaatgag agtttagtat 9360
ccataacatt ccccgagaga aaaatctaga gaccactgca gtttgaaaag catgaaaagg 9420
gagaggaata tgtttgctgt tttttgtttt ttgttttcca aacaaagaga atactgatga 9480
agaaacaaag atttggaatt tagtaaagaa tagggatcat ttgttaattt tcagaagctt 9540
ttaggataaa taaaatgaaa aagatgctgg gttattttgg catagagttt gatacacttg 9600
actaaaagat ttaaaaatat acctacatgt caagaaaaac tgaagtattc tatacctttt 9660
actacttcta cttagcagag tttatcttga gccactgtcc gtggcatgtc caataagttg 9720
taaaggcttc acacacactc ctcatatgaa caagttgctg aaatattgtt aaagtgtcac 9780
attttgtcca ttataaggta aattgttttt cacaattcta ttttctttga aatacgggta 9840
agtcctataa tcaatcttca cctttaatgt ggtagtacta aacaccaccc aaaagtaaca 9900
attagatatt taatagaaca tcttataata gagagaatct cagaatcaaa taaataagat 9960
gggttagttt ttgcaagcct gtctttctgg agtttcctag tattctttag agtgttaggc 10020
ctatcattct cagttaccca ccagactgta ctttactaag gcacaggcaa ctgcaagagt 10080
cagacaatac ttgatagtgt tgatattgac acttgagatt tgtgatcgca taggcattga 10140
tttgagtcct gactctgtta cttactcttg gattatatga acttggatag gttatttaag 10200
gtctctaggt cttatctgta aaatttccta atccgtaaaa atagtgtgat gataataaat 10260
agcctagcca aaaaaataga cttaaataaa tgtatgaaaa gtagagtaag tgctcaaaaa 10320
cttagctctg cttttatgca aaaataaact attttaagca gttacatgat acgagaaatc 10380
agcttgataa tggaaaaaga tcataccatt gtggtcaagt tttacacaaa catgatctgt 10440
ttcgtggcct agactgagtt gaattagaat agaagaaacc atattacaag tattcaggaa 10500
ttaagcaaag acaaaaaaaa atagttatga ctgtgataac tgaaacaagg gaagagatat 10560
aagagacaat gcatttaatt tgtgaattga caaataaggt aggtgaggaa aaaagaggct 10620
tatggaattc ttgaacctaa catgcaagaa gagcagggat gcaatttatt gggagagggg 10680
aattgaggaa taagagcccg tttattggtg tgtgtacgtg ttgggggagg aaggagttca 10740
gtttgggaca accatgaaga cccagcagac agctgaaata ctgtaatgaa gttcccttat 10800
attctaacat attactttta gttctttgaa gtcaattctg caccccactt tttgctctac 10860
acccagacag tagcacagat tggtgttcag taatgacaga tggaaaagtg atgggagaat 10920
ggtggtgagt ggctggtgca tgctgtgaga cttgtgcatg aagactcatc ctgagtgaag 10980
agccacacgg ttccaccagg gggaagactg atttttgcat atcatgcaga aactcaacca 11040
cctgttagag gagggaaaca gagtgggaag gaactacgct gtaggaagga aagatgaact 11100
tgagtttcac ttcttagtgc cttttctcag gggagaggcc atcacttgaa gatgctgagt 11160
cttctgctcc ttctcctggg actaggtatg agccttgtct tttgaggagt ctggggttaa 11220
tgttaacact gggtggaaag gtggaaagac tttctctcca gagagtctga agccaccaga 11280
cagaagatga aggggatatg ttagattaaa gaaccataac agagtaattg ttggcacaat 11340
aaaaaggagg cagttccctg gggtcctttg ggagctgagg tggtattgga gagataaagc 11400
agagaccttc ctgcctgggg agatgtctga ccccaagctt gtcggtcctc atgaatatct 11460
ctctggaact aggctctgtg ttcagtgctg tcatctctca aaagccaagc agggatatct 11520
gtcaacgtgg aacctccctg acgatccagt gtcaagtcga tagccaagtc accatgatgt 11580
tctggtaccg tcagcaacct ggacagagcc tgacactgat cgcaactgca aatcagggct 11640
ctgaggccac atatgagagt ggatttgtca ttgacaagtt tcccatcagc cgcccaaacc 11700
taacattctc aactctgact gtgagcaaca tgagccctga agacagcagc atatatctct 11760
gcagcgttga agacacagtg cggggcacag atcaaagatc tgagcaagaa cctcagctct 11820
ctcctaccca gctcctctca cacgagcctg aaggccctgc caaggtggga cagaaggagg 11880
aaaccacagc ttttgggcag acacagctgt ttctgtgttt gtgggtgggc atgggtatga 11940
atggatagac tggggatgag gagagcatct gtaggactag ctggagcgtt ctatccacag 12000
gcaggaagag tggctcctgg aaagctgagg gtaaaatttc ttctagaagg gtgctcagaa 12060
atacccaata aaaacaatca gatacagttt ccttcaagtg gcggggtcag taatagcctt 12120
taactgtttt atctcaaggc tctttttagc tggttttcta tcataatata ttttggaaga 12180
actttagtca tcttgaaaca aagctggtac attatattaa tgacatctgg ttgttctcag 12240
tgaataggaa tgataaagcc ctctagatgc ttcaatatga caatatgaca catgcatccc 12300
aggccaatat aaaatctgca aagttcagga accttctata ctggtgagtt ttggagtggt 12360
ccagatgtaa gaagtaagct gctgcacctt agatcatgta ccacggagaa agaggtgcaa 12420
tgcttagtct ttggactttg aattaaactt tggatatact gcatttgatt gtgctactct 12480
atcccattta ctatgtaatc tgtaaagctg gggccagtgc aagagagggt tctgtggcag 12540
aagaagccca tgatgaaagc ttcctgctgc ttgggccatg gactaagcag acccagttgt 12600
tcttgaagag cctatggtag atactgatgc cctgtggagc tcctgacatt ccccaatacg 12660
agaatcacaa ggcagtgtgg aacaggtttg ctgtgccctg atttgcactt cagaccattg 12720
catcttgggc tatacttttg ttgctttcca gatcccagag agaaagaatg ctcacacaca 12780
caaattacat gaggagtgtt tattacttac atacaggcag caagggaaaa cagaggccta 12840
agattcaggg aaagccagtc ccactaggct caggaaagct gcccagggtg gatgaaatct 12900
tgtctgtgcc ttccctactt gcactgccac tgagggacct cagagagcag ccaccctggg 12960
ttttatatct tagagcaact tgacatgctt ggcaaagcat tgaaggacat tctatttcta 13020
gaagggactg gaacagagcc ctggctgttc tggccagttc ctccttatct caggatgtta 13080
cagtcccaga acattgtaca gttatttttg agaactacaa gcaagaaata ggggagtact 13140
gagtttgtcc aaggccacct ggagaattgc cctgcagaca ggtgcagagt tttggtgtaa 13200
agccatactc ttaccggcca acgatcccct ttcttttgaa aagttgctcc tggctctata 13260
atggatgcct cataatggca ttcagaacaa ggtattatct gatctgcaaa actgtaaatt 13320
tggctgtgcc cagagcattc tgttattaaa tggaaaatac ataatcaaga ccatacttaa 13380
gcacagctgg aaaaaggcac gattcaattt caagagcaca tctcagagtc tcatgctacc 13440
cactcatact tttctcctct taccttcaaa ccacacccaa gtttcatgga aattccatat 13500
ttccagttga gaaacatgag cttatttttt tgatgggtct tcacattatt ctggaaggat 13560
cattacagtc taaccaagta tggttctgaa aggtagtggt gaagggaaat cttctcgggg 13620
ccaaaactta aattggtata cctgattgtt gtccacattt tattgaagaa gagatggcca 13680
gaagtatagc tatatcttat gttcaatttt ctttcatact atcatctagt ctccttacct 13740
attcagtcat atttttcttc tttttgcttc tctatgctac aatctgggta atttctttaa 13800
aactactgtt tagtttacta attcacacct cagctccagt aagcctctaa tttaatcttt 13860
caactgactt tgttcatcta aattatatta atttttattt ctagaaaatc cacttgggtc 13920
atttacaaat atgagtggac atttttgaaa gcatcttgtt ccttgtgtat tttaaaatta 13980
ttttcttttt ataagtatat taagcatcta ctgggaatta ttatctgaca atgccagcat 14040
ttgatgcctt tttgcatctg gctttcagtg gtctgctggc tctcactcag ggtagcctat 14100
ttccttgtac attatgtaag ttaatgtgaa ttcatctttc agaattcttt aaatactgga 14160
gtaaaagtgg gttttctagg aaaattcatg tttgcctctg tcaagaaatt ggggcgctac 14220
agacctaata tcattttatt ttataattct cagtatatat cttcttggtc atagaatgtc 14280
tatctcaaac cccaatgggc tgactgttca gtgaccatga atattcagag gaaatttttt 14340
aaaatccttc acccaaagcc aagaccaaga caaataatat tctttgttaa ttgcttctag 14400
gattagtttt ctagctcatc ctttcactaa ctgtgtatct ctttgtgtac ctcactttaa 14460
aaagcagtga ttcctgtcta gtttctggtc catgtaaggt ctcatgggcc ttctccagtt 14520
tccatgtgta ctaattctcc aggtcacagg aatgcacatg tatacctgtt ttatctcatg 14580
ggctcagtgc tagcttacct tcctggccca tgctcccatt accataggaa gttgacaaat 14640
ttacctacag tgaagccttg gattatgaag caccttccta tattacaaaa ttgcctcttt 14700
aaaagcagta aagcactgtg gttaggaact tgaactttgt caagtgacag acctaagttt 14760
aaaacttggt tcttctgctt taacactagg tgtaacctta acaagttaca caatttctcc 14820
atgccttaat ttctccatag aaaataagaa taatagtgag tttttaaatg taggtttttt 14880
aaaataagaa agtgatacaa ttatctgtat aaaaagcaca tagagacaaa atatgcaatt 14940
agtgtagttg ctacctaaac gtatttctca ctataaaaac atattttacc actggcaatt 15000
ccttcctcaa gaataagtat ggccctctct cagaaaattt tatcattaca attgtttctc 15060
ttttagctat tttaattaaa taaaaaattt gtggtattat aaaatatgca tattatcaaa 15120
ataaaaaagt caaaatcact cagtttaata aaattagatc atacaatatg tagttttaga 15180
atttattccc ttaacccaac aatatttcat gaatatcatt tcatgtcaaa aatattttac 15240
attaacttta ataagaatag ttcgatatac tgatgaccat ccttcataca atcaaaaccc 15300
atgacaaggt atatatccat aggctagatg acagggttat ttaattttaa atagcaattg 15360
tttgtgtgcg ttgaattatt tctgttgcag actcagaagg aaatcatgaa agccctaagt 15420
ctacctgcag atggctggtt cttttttatt caggtgttaa cttaaatgcc acctccccaa 15480
agagaccttt cctgaccact ctacgtaaca gcacttcagc agtcatgcca tattatcact 15540
ttatcctatt ttagtaatat gtactcatca tttactgaaa gtgatgtatg tgcatcccat 15600
ttctatacct cctcatatgt gcataaatgc atgcacatgc acacatgaat gcactgaaaa 15660
caagaacctt ttctgtcttc ttcgttgctg cttccaaata gcctagaaga actcttggaa 15720
tatcactcca ggaattcaat aaatatttgt gagtaaataa atacatttca aagataagag 15780
gaaaatttat acagctgcag tggatttccc tggtggaaaa ctctacaaag gcatttgagt 15840
ttagataatc taagcccata agaaaattaa ctagattatt ctaacaggaa aggaataagc 15900
acttcaaact ttatattttt tattcttgtt ttaaatttat gttttagttg cggggaggat 15960
acaaaaagat taaaggacac aaaattacag ctagatagga ggaataagtt ccagtgtttt 16020
acagaactgt aggaggacta cagataacaa gcattgtatt tgaatagaaa ggtccatatg 16080
tcatgtgcca accccgttct gctgccttac ccaagactgg gaaatggaac agatgatatg 16140
ggttctatag agaggcaaag tgcagaacct gctcaaacac agtggccctg gggtggaaag 16200
ttctcaattg gaattgtgtt ggtgcctgtg tggatggagc attcaattct gagccttagg 16260
agccttttga aggccctcct ggccaagatg atcttgagga aatgactgac ccattggctg 16320
ccttccaaat ggatgacaca gtctagactt ttataaacta catgagtaga aggaacccag 16380
ttgactggat ttatcaccaa acctagcttg tgagcctcag tctagagcta gcataattta 16440
gaaaaataaa tgcatacatc atatattaaa ctctgagtat catgaaacag atcctagatg 16500
ttacaataat aagaacctac atgggtgttt ctcctgcact ctgtcctggc tttcttctgc 16560
ttcttgtcta agggagcctg gactcactta agcagctcta ataggccaaa caagagagtg 16620
gtcaaggagt ggctgaaatg tgaacagaaa gactcaccat tatattagag caatcaatct 16680
atccttaaaa tactgtgggt ttagtgtcaa gtgctagagg cttccccatt tacccataca 16740
tggaagcctg aagaataaac agaactataa acttccctct gggcataaaa cttgcatgtc 16800
ttccatggct tcaagctggg gagcagctgg gcaggcagaa ggaggggcaa gaggcagtca 16860
agaggagggg cgggaggcag gcggggagga atgggctact ccgtttagct gatcagcctt 16920
gaccagttca tgctctggga ctccatctta caagtcagac ttttccgagt cacacagagc 16980
actcccttca ctctccagat tcaatgattc ctgggatgat atagtaacga aaataattcc 17040
ttattggata aagagaaatt gtgctgtgcg ggagataagt agcttagaaa aaaaaatgga 17100
tgaggagagg agctgggagt ttgggggtaa gacagcctaa aatctgacag tctggttggg 17160
gaacgataaa agatactgga acccaaggag gagatcagta agaatgtagg agaaagatct 17220
ggtgggattt ggagaagaaa gtgttaaaaa ataaaattgg aatatgacag tttgcagact 17280
actaggtctg aaagacgcaa ctctgtagca acatgaaggg gaacaaactt tgtctgaata 17340
gggaagtttc tagtatgatc tctgctttcc ttagacaagt aaccctggag aagacacttg 17400
acctctgagc tttagattgt tcatctgtaa aaaggagaga acaatatctg ctgcctacca 17460
cctcagtgag gctgcactaa ggatcagctc agaggaggca aagcagaatg ccctattgca 17520
cagcatggag gccctagagt cggaccacca tacttacatc ccatctttaa aacctcctgg 17580
ctgtgtggcc ttgagcaagc cacttcacct ccagaaagtt catttgatca tctgtaaaat 17640
gggcaatccc ataggtggtt gtgatgataa aatgaaaaaa acatttttaa cttacatgag 17700
ttacatgctg tagagtaagt tatgtggtat atagtaagca cacagaaaag actcactgtt 17760
atcaaaatta aaggaaagtg gtttagtgtg ctaagcacta aatacaagcc agagagatgt 17820
cttgagaagt agacaaagaa atctacaatt cagaatgaac agtaacaaga atgacatgtc 17880
ctccaaattg agctttggca gctggatctg aacctatcct acacatctga gtctacagta 17940
tgaggtaaca gtctccacct atagctatct tctctgcctg taaggtcatt cctttctgaa 18000
gaaagctgac ctcagactat tttgcgatca tttaaggaag agcgcaaaat actggagaag 18060
gctagtcttc aagctctaga tacagaaaat cctcaaattc ttgggtgttc cctttcagac 18120
tgagagtcag agccacaagc actgatccaa aaatcccctt ttccaaaaaa attttccatc 18180
ttctaccaag gttcacctcc ctgtttagtg cacactagta tctacagttg ttagagcagg 18240
agtctctcct tatcctctaa ggcaggtgtt ctgtgaagac cccatgacaa gggacaaaat 18300
gaaacaacat gttcagggac aacaaaggaa aagcccattt tatcaatgct ccaaaacctg 18360
gctacctcag gcttggcaag ttattcgtga gcagagaagt ttgtcatcta catggcagtc 18420
atggcctgga tgggtctcga actgtggcat ggtaatgctc tgagactagg tgccaggaga 18480
aagataaatt caatcatcca tttctaccag gaagaaaagc accaggaagg aatcagatgt 18540
acagtttgtc ctctagggac ctctgtcttg atcctcaata aatctccttt tagatacctc 18600
ctcttagatg aaattcccac acttcacaat gctctccatg gcttctgttg gccttatggt 18660
cagctctgcc aagatctgta ttcttgggca agacagaatc cttctgaatc tcagtctctt 18720
gctctataaa tggaaacaat tttgctctgc acaaattaca attagcatgt ttgtgggaag 18780
ttaaagtgtg aaactcagca taaatgaaaa gtaatgtacc actgttgctt acatgaaaac 18840
tcttgtaaag ttgtcaggca ctgtgcacca tctaagcata gcagtgttag gtatgggccc 18900
attagtgatt agagggggtg cgaggcggag agggggtctc caagcagtgg gtctcctggc 18960
tgtggggaag ctggctcagc agccatacca ggagctgaaa ccgaaggtac tctgtgtgtc 19020
ctctcaacac catgggcccc actttggcat tatttccaat tccctctggt ttccatttgc 19080
ttcctccctc tagccccctg gccaggtccg atttcaacac caagtttctg agcttttccc 19140
attttgtcca ccgtctctag aacatttctg cttcttttac ctttcaaaga atccaaactt 19200
gaactctact tactcctgcc catcaccagc ctgagctcag agttgctgag aagggaaagc 19260
accctcataa ggaagctcct cctttcccta catcattaga cttgagcaca gacagcatct 19320
ccatttccac actgctctgg ccaggttgtg cctcagtcaa ttacacaact gtgtcttagt 19380
agccttggta gggcccaaat caggatattc tctaggaaga ttcactttgt actgagccaa 19440
gcataatctc actgcatcga aaatagaaaa tgatcatctg atcattctgg ttcagactgt 19500
cagccctgag caggtgggtc agtttgcatc acctgagtgc agattgcaag gacaacagtg 19560
aggctgcata aaaagaacct atgacaggat gcacatgaga gagacaaatg tcttcacatt 19620
gaagaagggg aggagtgcgc cattggtttt ccatcctcca gaggcactga gaaagctcct 19680
acagaaactg tgccccctcc ttctttgaaa cacttcccat ccttaagcct tggtaggaag 19740
gagagaaatc tggaagccca gaatcctatg gaatgctgag tctcccttct ccttacccct 19800
tagtgttgga attttcattc cccaaaatct tgcatttgac cttcctgcac actgactgga 19860
gagaagcatc ttcatattca caggaatgag ccttagataa gactttgctc ctctcatgtg 19920
ggccccagga aactgaaatc caagcttttt accaatgctt gcccttcctt aagtacatta 19980
aatacattcc caataggtgg aaagatttgt aaacagctag gccattctcc ctccttctaa 20040
ccctcatctc cagggcctaa gaaagcccag ctctgttatc tggggcttga ctttccctgt 20100
cttccccatc ccagtatcct tgcaggaaac agccggtctc gctctctgct ctcagaagga 20160
aagtttcctt atcacctgtg aatcacaaac ccagagagtg gccaaacata gccaggctga 20220
tgcaagaccc tgggaagagg aaagctgcag gtgtgtttgt gctgggagga gtggtgaccc 20280
tcacctcaca gtcacctcct ctctggatcc tcgtgaggta taaagacgag tcctccacca 20340
ccagtcaggc acactctacc accatgaatc cactcctgat ccttaccttt gtggcagctg 20400
ctcgtgagta tcatgccctg cctcaggccc caaccacccc cccgttcctg gccgacaaat 20460
gcccttccat tcttaccacc tctcctcttt tgactgtgct ctgatattcc gtttcctcca 20520
tctggcatat ctccttccca tcctccttgg gctcttttta agtctcacct gttcaccttc 20580
tccttgactt cactcccacc actgtcattc atccatatcc gagttgtggt tggagaagct 20640
gggaaggggg ccaggtgggg ctgtcccacg aaatgaagca gcaggcttca ggcttggctc 20700
caacagcaac agaatagcac cactatagct gctcctaacc tcgaatgcac ctggggaggt 20760
tgaaaaatta ctcatgccag agactcagct ctagaaattc taacttcaat tgtctggggt 20820
agagcttgtg ttctgggctt ttaagcttcc caggtgattt ttaatatttc cagccatgca 20880
gccaaggtta agaattgctg tcctattggc caataacaaa gtctaccttt gttctgccaa 20940
agtgagcctg ggggctgccc tcaactctgc cctgactgca cagatctgag ctatggggga 21000
aggtggtcat ggccaggtct atgcagacag ggggttttcc tagcttggca aaagaatcct 21060
gacaatccag ggcccaaata gccaggggaa gtacacaggt gatgaataaa agagagaagc 21120
actcagtggg agagacaacc acatcccaac tcctatccca ctggaagcat tgtgaggaca 21180
ttccttgcga cttcagcctg gtgaccccag gagagctcgg atcctccgca gggtacctag 21240
ctatgtgccc tgcaggcaca gagacttggg agccacaggc agtgatgatc accaggggtg 21300
gcagagctcc ctcccttgcc tagcctcact gtgcttgtta aggatttcta attagcagaa 21360
agcaatcaca ggctgggagc gccaccccta acatgctatt gacttgcctt ctcccttccc 21420
atctccactc cagttgctgc cccctttgat gatgatgaca agatcgttgg gggctacaac 21480
tgtgaggaga attctgtccc ctaccaggtg tccctgaatt ctggctacca cttctgtggt 21540
ggctccctca tcaacgaaca gtgggtggta tcagcaggcc actgctacaa gtcgtaagtg 21600
tggggccccc gactgcaaag ctcccggcca gtctgcctgg gagagcttgg cttcagccca 21660
gggaactact gaggttgggt aagatggatg ggagaggtgg tggagaagaa aacttgttgg 21720
cagctgcgga ctctccagag cagagagtga acacaagaca ggaacctctc acacccaggc 21780
aaatccatga aacagcaagg gttgtggtca taaaagcagg cagggatgat cttggggtgg 21840
tgagagctag tgagaaaagc aggcaagtat cttttgctgg ttagctacac attaaagcca 21900
actaagaaag actttttaaa aatacagatg cctttgtcct atcccagggc aattaagtca 21960
aaattttcag gaagagggtg tgaatatcag tgagaatttt acactctacc tctgctaact 22020
gtagagtgta tagacagagc tgagaactgc tgcctacacc aagaactctc aaacctgagt 22080
atgcatcaga acgccctgca ggcttgttaa ggcacaaatc actgggcccc ttccccaagg 22140
ttctgatcag taggtggggg taaggaccaa gaattcacat ttctaacaag ttcccaggag 22200
atgctaatgc tatggctacc cttggattag attacacaga agggtggttc tcaccaggcc 22260
aagaatggag ggaggaacag gcactgtgca cagttggcaa aggcctgggg tgaagaacgc 22320
tgggaaaact tcaaggagct ccttgtgccc acagtgctag tgactgtgga gattgtggga 22380
aagagtctgg ggaggcaggt tgaggagcag cctctggtgg gatccctttg actcttcccc 22440
accccactac caccaacctc tggagcagat aggtcctggg tctcatacct tcactgaccc 22500
acatccctct gctgcccatg cgatatggcc acacacccca ccccatgcct ccagagctgt 22560
ccatgagcag agagcttgag gaacctgggg aaggtgggat aggtgccctg gctgtgggag 22620
aaggtcttca ccatgcctgc cctgcccatc agccgcatcc aggtgagact gggagagcac 22680
aacatcgaag tcctggaggg gaatgagcag ttcatcaatg cagccaagat catccgccac 22740
ccccaatacg acaggaagac tctgaacaat gacatcatgt taatcaagct ctcctcacgt 22800
gcagtaatca acgcccgcgt gtccaccatc tctctgccca ccgcccctcc agccactggc 22860
acgaagtgcc tcatctctgg ctggggcaac actgcgagct ctggcggtga gtgggaccct 22920
tagtccttct acttccctcc atcctcacaa tttccagaac aaaccatgcc ccttaacttg 22980
aatcctctca cctccaggct taagacacat ttcgagtgcc cattacacac agactctgca 23040
ctgggcacca gagagatgca aactatcaag gacttggctc ctaaaatcaa gagacaggac 23100
aaatggagaa cttgatatga tcacatcttg ggaggggttc aacaatgatc attctgggaa 23160
ctaaaagcca gagtctcttg ccaggactta tgttctggag tcctctccag gggctgtgtt 23220
cctcttcagt tttccatcca agattattgt ctccttctct ggcctgaccc acatttctac 23280
ttcctttgat ctcttcctga tcctcacagc cgactaccca gacgagctgc agtgcctgga 23340
tgctcctgtg ctgagccagg ctaagtgtga agcctcctac cctggaaaga ttaccagcaa 23400
catgttctgt gtgggcttcc ttgagggagg caaggattca tgtcaggtga tttgaccaac 23460
ccttcccatg ctgaggctcc cactgatacc taggccccac cagggaaaag gatttgaact 23520
caaaaggtgg tggggctgag gaggctccct gcagtgccca catggagaag tgaggaagac 23580
tcccttgggc tgcatcttgt ctgcttagga agaacagaga atgggccacc atgagaagga 23640
catggagcca cagagctggc tggaaagggg tcttttaagg ttcagagtaa atgtagctat 23700
attcctcctc catctctcca tacaacttgt cccttcttcc ccccagggtg attctggtgg 23760
ccctgtggtc tgcaatggac agctccaagg agttgtctcc tggggtgatg gctgtgccca 23820
gaagaacaag cctggagtct acaccaaggt ctacaactat gtgaaatgga ttaagaacac 23880
catagctgcc aatagctaaa gcccccagta tctcttcagt ctctatacca ataaagtgac 23940
cctgttctca ctgtctgtgt ctgtgcctgc tccctctcac tccttcacac tggaaagcat 24000
cctccaattt caggttagac acgactgtcc cctttaaagg taagcagagc ccccatctcc 24060
caaaatgtgt tccatggtac actagattag cacatacaaa cagatggaat ccaaaaataa 24120
gaagaagctt gggagaaagg ggagtactgt tttctagaga tacctgtttc agaaaggtgg 24180
tctttggggt gggggggtgg gtattgattt ttatttgggc ttctcacagt agttagagct 24240
actctgcctt cagaacaatt acagcacaga aaatgtgtca gcatcttcga ggtggcccaa 24300
aaaacttgac cagctgaatc ttcttgctaa aatacaataa taatgacaaa tcctgttggt 24360
gatgacgtgc ctctcccagg aatgtgtcgg caccaaaccc tcgaccaagc cctcccttct 24420
cattcacctg gaaaatcaga tgcaaataaa tctccctggc cgcctaactc ttccctcagt 24480
tccctagttc catctctgtg agcaggctag agagatgttc cacctaccat agcaggagcc 24540
agactgcgac ttgggaatca agcgcagatc tacacactgg gcttgatttt cgtcttcttt 24600
gcctttgggg taggatgcca cagtgaatcc cacagctaac accagctcct cactctgacc 24660
agggaaagaa actagagagg gtcaggattc acctatttga tcaattagct gaggaaggat 24720
tcattttcat aaaacttgct tgactttgag acacttcaag tgagttattt gggattcttt 24780
aaaaggggtg gaaggaaaga tctgaggact gtgacaccac cagccactct gaccacacgt 24840
tggctggctt gaacccactg gatgcagcag agggaggcag gccctgtggc acctctggca 24900
cctgccaaag cctcctcctg gcaattctga gagggcccat gttggggctg tagctcatcc 24960
aagcttggca ccgaagatcc aaggaagctt ctctttgaaa ttccaccttc acctctgtcc 25020
caagtggttg tggacacccc tgggagctgg cactaagggc caggagcagc caagggagac 25080
agacaagttc agagcacatt tccagttaca gggaacagag cacaggcctc caagtgtcca 25140
cagagcagcg tgcaaattgc agggatgagt agaggaaaac ctctacatgg agcacagcgt 25200
tcctggcaaa cacaggggac tgcagtccac atgctgtgga atacacccaa gtatgcatca 25260
gacacttgtt tggtaaacag taaatgtgta agatcaatta ccttgagagg gccatctggg 25320
ctccagatgt gtgacttgtg tgaggagacg gctaccactc actatctcca gaggaaaaca 25380
gggctcaggg ctcgcacaca atggatagat acacacgggt cacccagaac atcaatacat 25440
acaaacatca ctttgttcaa catggatttt gtttttatgg agtccaaacg cagaccgtag 25500
ttcaccttac agccttgggt ttgtctgctt ttggagatat atatccagta gatagataga 25560
cagacaagac agataatttt ttccctttct tactataata tcaatgcctt atctgaatat 25620
catcatcact caagagtcaa gggaagaacc aaacgcttca tataaacagg gctgggctgg 25680
gcagggagtg ttagtttcca ctgttttctg tctccattca gatcatccct atcaaagccc 25740
agctggtcac ctcaagccaa gacacagaca taaggatccc aatggccttc cagatggctg 25800
cttccacctc ccacctgggc cactaagact ctttacacag gaaagtgagt caccccagtg 25860
agaagggttg ccagaagaaa cagggcatga aaatcacaga taaccatggg atttcttcca 25920
agtggtcagt ataaaatata ccaacactac catcaccaaa aacacaaaac aagcaaaaac 25980
atgcttattc aaaatcctag acaaaatact gtgtgagagc caggccacgg ggttgccttt 26040
tcacaggcca cacagctttc ccagtccatg tactcacgtg gaaccgtgag atgtgaaagt 26100
ctgcagggtg tgtgctcagg atcgaggctg gtactgttca cctatgggtc cagaccaaag 26160
ggcaataagg cagaaagctg atatctgtcc accgccacgg cttagggcct ccttctcaca 26220
gaggctccta agagccccca cctcagcctt cacacaaaac atctccttct ggctgaacta 26280
cagccaggct ggagtgccgt ggcatgatct ctgctcacta cagtctccac ctcccgggtt 26340
caagtgattc agcctcccaa gtacctggga ttacaggcac tcgccaccat gcccagctga 26400
ttttgtttgt ttgtttgttt gtatttttag tggagacagg gtttcaccat gttggccagg 26460
ctcattttga actcctgacc tcaagtgatc caaggtactg ggattacagg catgagccac 26520
cacttctggc ccaggaccca ttttttaaaa aaattttcaa cttttatttt agattcaggg 26580
catacgtgtg caggtttgtt acatgggtat attgcgtgat gctgaggttt ggggcacaaa 26640
tgttcttacc actcaggcag tgagaatagt gcccaatagg tagttattca gccctttcca 26700
ccctccttct ctcttccctc tagcagttac agtgtctact gttcccatct ttatatccat 26760
gtgtaccaaa tgctcagctc ccacttatac agaagaacgt gatatttggt tttacatacc 26820
tgtgttaatt tgcttagaat tatggtctcc atctccatcc acgttgctgc aaagacatga 26880
tttcattttt tcatagctgc atagtattcc atggtgtata tgtaccacat ttcctttatc 26940
caatctaccg ttgatggcca cctagattga ttccatggct ttgttattgt gaatagtgct 27000
gtgacggaca tgcaagagca tgtgtctttt tggcagacca attattttcc tttgggtata 27060
tgcccagtaa aggaattgct gggtggaaag gtagttctgt ttttaattat ttcagaaatc 27120
tccaaactgc cttctgcatt aatttttcca taaactaatc gacagtcagg ccaagagtgt 27180
ataagcattc cctttcctct gcagccttga cagcatcttc tatttttttt tttttttttt 27240
tgacgtttta ataatagcca ctctgcagcc aagctctttc aaggccaatg tggggtagag 27300
ccacaaacat cccttttccg gaagagaatt cttgcctgcc cactggtaga attcttgttt 27360
tcatctgtct tttattattt gtttttcaaa gaaaaactgg cctgtaatcc cagcactata 27420
cgtggccgag gcgggcggat cacgaagtca ggagatagag accatcctgg ctaacacagt 27480
gaaatcccgt gtctactaaa aacataaaaa attagccggg tgtggtggca ggtgcctgta 27540
gtcccagcta ctcgggaggc tgaggcggga gaatggcgtg aacctgggag gcaaagcttg 27600
cagtgacctg agatcatgct actgcactcc agcctggaca acagagccag actctgtctc 27660
aaaaaaaaaa aaagaaagaa aagaaaagaa aaaaaagaaa aaccaaaggt aaagtggtaa 27720
gatcttccac acctgaacca gtttgtagcc accagagcct gctgcgaagg ggcccctcaa 27780
gcatgcattc atcttgtcac ctggaatttg agagatcaag aagccccata gcaacctacc 27840
atgcaactgc ccatcagtgc tgatcctttc aagggattat ctcaattctg actctgcaga 27900
cactggcagc cacaggtgac aaaccctgtg tatctgtggg ctttcctcat cacccagggc 27960
cacaatgggg tgcctgccct aggcagagac acagcaacat tctcttaaac tgaaattaag 28020
cataaatcca cttcaccaat aatcatctga gggctcagtc cctgtctcct tcctcgggga 28080
ttttaaaaca cacatttctc tgaccaaaca ggtaggtgag atctgacttt aaagggggga 28140
aattgggttg aattgaggta tcaggaatgg atcacaagtg tttttgtgtg gggacaggca 28200
tccacatccc gaactgtacc tggagatgga gaaaaatgca ggagaggaga agagaaaaaa 28260
aggaggaaaa agtggctgaa agtatttgaa agcttctctc atggttcttt ctggctctgg 28320
ttgcttttcc aaggtcttga gtgcaggcag ggccagctct ggctgggagc tgctgctctg 28380
ggacatggaa gagtcacttc acctccagaa agttcattcg atcatctgta aaatgggcaa 28440
gcccataggt ggttgtgatg ataaaatgaa aaaaaaacat tcttaactta catgagttac 28500
atgctgtata gtaagttatg tgctatatag gaagcacaca gaaatgattc actgttatca 28560
taatagaagg acagtggctt ggtgtgctaa gcactaaata caagccagaa aaaatgtctt 28620
agagaagtag acaaagaaat ctatagttca gaaccaacag taccaagaat gacatgtcct 28680
ccaaattgag cttgggcagg tagatctgaa cctatcctac acatctgagt ctatgatatg 28740
aggtaatagt ctccacctat agctatcttc tctgcctgtg aggtcattcc tttttgaaga 28800
aagctgacct cagactatac tgtgatcatt taaggaagag cacaaaatac tggagaaggc 28860
tagtcttcaa gctctagata cagaaaatcc tcatattctt gggtgttccc tttcagacag 28920
agaatcagag ccacaagcac taatccagaa accccctttc ccaaaaacgt tttccatctc 28980
ctaccaaggt tcacatccct attgagtgct cactagtgtc tatagttgct agagcaagag 29040
tctctcctta ttctctaagg caggagttct gtgaaggccc catgacaagg ggacaaaatg 29100
aaacaacatg tttagggaca acacaggaaa aacccatatt atcaaagctc caaaacctgg 29160
ctacctcagg cttggccagt tattcatgag cagagaggtt tctcatctac atggcagtca 29220
tggcctggat gggtctggaa ctgtggcaag ataaggctct gagacaaggt gccaggagaa 29280
agatgaattc aatcatccat ttctgccagg aagaaaagca ccaggaagga atcagatgta 29340
cagtttgtcc tctggggacc tctgccttga tccgcaataa atctcctttt agatgccacg 29400
tgcagcaatt cccacacttt acaatgctct ccatggcttc tgttggcctt atggtcagct 29460
ctgccaagat ctgtattctt gggcaagaca gaatccttct gaatctcagt ctcttcctct 29520
ataaatggaa acaatttggc tctacacaaa tcacaattag catgtttgtg ggaagttaaa 29580
ccgtgaaact cagcatcaat gaaaagcaat gtaccactgt tgcttatgaa aactcttgta 29640
aagttgtcag gcaccatgca ccatctaagt acagcagtgt taggtataag cccatcagtg 29700
attagagggg gtatggggtg gagagggggt ctctgagcag tgggtctccg ggctctgggg 29760
aagctggctg ggtggccata ctaggagctg aacccgaagg tactctgtgt gtcctctcaa 29820
ctccacgggc cccactttgg cattttctcc aattccctct cgtttccatt tgcttcctcc 29880
ctctagcccc ctggctgtgt ccaatttcaa caccaagttt ctgagctttt ctcattttgt 29940
tcactgtctc cagaacatcc ctgcttcttt tacctttcaa agaattcaaa cttgaactct 30000
gctcactcct gcccatcacc aacctgagct cagagttcct gagaagggaa agcaccctca 30060
taaggaaact cctccttttc ttacatcatt agacttgagc acagacagca tttccatctc 30120
cacactgctc tggccaggtt gtgcctcagt caattacaca actgtgtctc agtagccttg 30180
gtagggccca aatcaggata ttctttggga agtttcactt tgtactgagc caagcataat 30240
ctcccgggat ctaaaataga aaattctaga cccacccctc cacatcttcg ttattgaacc 30300
caatatgtca cccatttacc atgtgctcaa atctctacct actgctgatt ctcagatcaa 30360
atcgtaaccc aggtttacca tggtccaaac tctgacatct gattggggcc atgtcatcct 30420
ggttcaggct gtcagcccca agcaggtggg tcagtttgcc tcaccctgag agcaggttgc 30480
cagggcaacc atgaggctgc ataaaaagaa cctatgacag gatgcatatg agagagacaa 30540
atgtcttcac attgaagaag gggaggagtg caccattggt tttccatcct ccagatgcac 30600
taagctccta cctaaactgt gccccctcct tctttgaaac acatcccatc cttaagcctt 30660
ggtaggaagg agagccatct ggaagccctg aatcctatgg aatgctgagt ctcccttctc 30720
cttacccctt agtgttggaa ttctcattcc ccaaagtctt ggatttgacc ttgcccgaca 30780
ctgactggag agaagcatct tcatattcac aggaatgagc cttagatcag actttgctcc 30840
tctcctggga gctccaggac actgaaaagc caagcttgtt accaatactt gcccttcctt 30900
aagtacatta aatacatccc aaatagttaa acagattcct aaacagccag gccattctcc 30960
ctccttctaa ccctcatctc ctcggcctac gaaagcccag atgtgtgatc cagggcttgg 31020
cttcccctgt cttccccatc ccagcatcct tgcgggaaag ggctgctctc tctctctgct 31080
ttcagaaggc aaatttcctt atcacctatg agtcacaaac ccagagagtg gccaaacata 31140
gccaagctga tgcaagaccc tgggaagggg aaagctgcag gtgtgtttgt gctgggagga 31200
gtgctgaccc tcacctcaga gacacctcct ctccagatcc tcaggaggta taaagacagg 31260
tcctccacca ccagtcaggc acactctacc accatgaatc cactcctgat ccttgccttt 31320
gtgggagctg ctggcgagtt tcatgccatg cctcaggccc caaccacccc ctttcctggc 31380
agacacttgc cctgccattc ttgccacctt tcccattttg actgtgttct gatattctat 31440
ttcctccatc tctccttccc atcctccttc ggctctcttt aagcctcacc tgtttcagct 31500
tctccatgat ttcactccca ccactgtcat tcatccatat ctgagctgtg gctggagaag 31560
ctgggaaggg agaccaggtg gggcgggccc acaaaatgaa gcagcagcct tcaggcttgg 31620
ctccatagca ccagtatagc accattatat ctgctcttaa cctcaaatgc acctggggag 31680
gttgaaaaat tactcatatc agagactcag ctttagaagt tctaacttca ttctctgggg 31740
tgcaacctgt gtactgggct tttaacattc ccgggtgatt tttaacattt ccatgcatgc 31800
agccaaggtt aagaattgct gttctattgg ccaataacaa tgtctacctt tgttctgcca 31860
aagtgagcct gggggctgcc ctcaactctg ccctgactac acaaatctga gctatggggg 31920
aagctggtca tggccaggtc tacgcagcca gggggttttc ctagcttggc caaagtatac 31980
tgacaatcca gggctcaaat cgccagggga agtacacagg tgatgaataa aagagagaag 32040
cactcagtgg gtgagacaac cacatcccaa ttcctatccc actggaagca ttgtgaggac 32100
attccttgaa tcctcagcct ggtgaccccg gggagaactg agcccctgca gggtacctag 32160
ctacatgccc tgcagacaca gagacttggg agccacatgc agtgatgctt accaggggtg 32220
acagcgctcc ctcccttacc tagcctcact gtgctcgtta aggatttcta attagcagga 32280
agcaaccgaa ggctgggagc gctaccccta acatgctact gacttgcctt ctcctttccc 32340
atctccactc cagttgcttc ccctttcgac gacgatgaca acatcattta gtggtatacc 32400
tgtgaggaga attctgtccc ctaccaggtg tccctgaatt ctgggtacca cttctgcagt 32460
ggctccctcc tcagcgaaca gtgggtggtg tcagcagctc actgctacaa gtagtaagtg 32520
tggggcccct gactgcaaag ctcccagcca ggctgcctgg gagagcttgg cttcagccca 32580
gggaactact gaggttgggt aagatggatg ggagaggtgg tggagaagaa aacttgttgg 32640
cagcagcgga ctctccagag cagagagcga acacaagaca ggaagctctc acacccaggc 32700
aaatccatga aacagcaagg gttgtggtca taaaagcagg cagggatgat cttggtgttt 32760
ggcagagcta gtaagaacag caggcaagta ccctttgctg gttagctaca catcaaagtc 32820
acttaagaaa gagtttttaa aagtactgat gcctgtgtcc tatcccaggg caattatcag 32880
gaattttcag gaagagggtg tgaatatcag tgagtattaa acattctacc tctggtaact 32940
gtagattgta tagacagagc tgagaactgc tccctacacc aagaactctc aaacctgagt 33000
ttgcctcaga accacctgca gggttgttaa agcacaaatc actgggaccc atccccaagg 33060
ttctgagcag taggtggggg taaggaccaa gaatttacat ttctaacaag ttcccaggag 33120
atgctaatgc tatggctacc cttaggttag attacacaga agggtggtgc tcaccaggcc 33180
aagaaaggag ggaggaacag gcactgtgca cagttagcaa aggcctgggg tgaagaatgc 33240
tgggaaaact tcaaagagct ccttgtgccc acagtgctag tgactgtgga gattgtggga 33300
aagaggctgg gaaggagggt taaggagcat cctccggtgg aatccttttg actcttccca 33360
accccattac caccaacctc tgaaacagaa aggtcctggg tctcacaact tcactgaccc 33420
ccatccctct cctgcccatg tgatatggcc acacacccca cccgatgcct ccagagctgc 33480
ccatgagcag ggagcttgag gaccctgggg aaagtaagat gggtgtccca gctgtgggag 33540
aaggtcttca ccatgcctgc cctgcccatc agccgcatcc aggtgagact gggagagcac 33600
aacgtcgaag ttctggaggg gaatgagcag ttcatcaatg cagccaagat catccgccac 33660
cccaaataca acagttggac tctggacaat gacatcctgc tgatcaagct ctccatgcct 33720
gctgtcatca atgcccacat gtccaccatc tctctaccca ccgcccctcc agctgctggc 33780
accaagttcc tcatctctgg ctagggcaac actctgagct ctggtggtga gtgggaccct 33840
ttgtccttct ccttccctcc atcctcacaa tttccagaac aaaccatgcc ccttaacttg 33900
aatcctctca cctccaggct taagacacat ttctagtgcc cattacacac aggctgtaca 33960
gtggatggac atcagagaga tgcaaagtct caaggacttg tcgacccatc cagctgcagc 34020
tgtcaaacat gagaattaca acttatatcg tatggggctg acttcaggtg ctacatttga 34080
agagataaat tgcactgaaa tctagaaata ttttatctga ttaataagat gatcttcttg 34140
agatcgtttt ggtctgcgcg taatctcttg ctctgaaaac gaaaaaaccg ccttgcaggg 34200
cggtttttcg aaggttctct gagctaccaa ctctttgaac cgaggtaact ggcttggagg 34260
agcgcagtca ccaaaacttg tcctttcagt ttagccttaa ccggcgcatg acttcaagac 34320
taactcctct aaatcaatta ccagtggctg ctgccagtgg tgcttttgca tgtctttccg 34380
ggttggactc aagacgatag ttaccggata aggcgcagcg gtcggactga acggggggtt 34440
cgtgcataca gtccagcttg gagcgaactg cctacccgga actgagtgtc aggcgtggaa 34500
tgagacaaac gcggccataa cagcggaatg acaccggtaa accgaaaggc aggaacagga 34560
gagcgcacga gggagccgcc agggggaaac gcctggtatc tttatagtcc tgtcgggttt 34620
cgccaccact gatttgagcg tcagatttcg tgatgcttgt caggggggcg gagcctatgg 34680
aaaaacggct ttgccgcggc cctctcactt ccctgttaag tatcttcctg gcatcttcca 34740
ggaaatctcc gccccgttcg taagccattt ccgctcgccg cagtcgaacg accgagcgta 34800
gcgagtcagt gagcgaggaa gcggaatata tcctgtatca catattctgc tgacgcaccg 34860
gtgcagcctt ttttctcctg ccacatgaag cacttcactg acaccctcat cagtgccaac 34920
atagtaagcc agtatacact ccgctagcgc tgaggtctgc ctcgtgaaga aggtgttgct 34980
gactcatacc aggcctgaat cgccccatca tccagccaga aagtgaggga gccacggttg 35040
atgagagctt tgttgtaggt ggaccagttg gtgattttga acttttgctt tgccacggaa 35100
cggtctgcgt tgtcgggaag atgcgtgatc tgatccttca actcagcaaa agttcgattt 35160
attcaacaaa gccacgttgt gtctcaaaat ctctgatgtt acattgcaca agataaaaat 35220
atatcatcat gaacaataaa actgtctgct tacataaaca gtaatacaag gggtgttatg 35280
agccatattc aacgggaaac gtcttgctcg aggccgcgat taaattccaa catggatgct 35340
gatttatatg ggtataaatg ggctcgcgat aatgtcgggc aatcaggtgc gacaatctat 35400
cgattgtatg ggaagcccga tgcgccagag ttgtttctga aacatggcaa aggtagcgtt 35460
gccaatgatg ttacagatga gatggtcaga ctaaactggc tgacggaatt tatgcctctt 35520
ccgaccatca agcattttat ccgtactcct gatgatgcat ggttactcac cactgcgatc 35580
cccgggaaaa cagcattcca ggtattagaa gaatatcctg attcaggtga aaatattgtt 35640
gatgcgctgg cagtgttcct gcgccggttg cattcgattc ctgtttgtaa ttgtcctttt 35700
aacagcgatc gcgtatttcg tctcgctcag gcgcaatcac gaatgaataa cggtttggtt 35760
gatgcgagtg attttgatga cgagcgtaat ggctggcctg ttgaacaagt ctggaaagaa 35820
atgcataagc ttttgccatt ctcaccggat tcagtcgtca ctcatggtga tttctcactt 35880
gataacctta tttttgacga ggggaaatta ataggttgta ttgatgttgg acgagtcgga 35940
atcgcagacc gataccagga tcttgccatc ctatggaact gcctcggtga gttttctcct 36000
tcattacaga aacggctttt tcaaaaatat ggtattgata atcctgatat gaataaattg 36060
cagtttcatt tgatgctcga tgagtttttc taatcagaca tgttctttcc tgcgttatcc 36120
cctgattctg tggataaccg tattaccgct agcatggatc tcggggacgt ctaactacta 36180
agcgagagta gggaactgcc aggcatcaaa taaaacgaaa ggctcagtcg gaagactggg 36240
cctttcgttt tatctgttgt ttgtcggtga acgctctcct gagtaggaca aatccgccgg 36300
gagcggattt gaacgttgtg aagcaacggc ccggagggtg gcgggcagga cgcccgccat 36360
aaactgccag gcatcaaact aagcagaagg ccatcctgac ggatggcctt tttgcgtttc 36420
tacaaactct tcctgttagt tagttactta agctcgggcc 36460

Claims (1)

1. A method for constructing a mouse model of human acute pancreatitis is characterized by comprising the following steps:
constructing a targeting vector plasmid containing PRSS1 gene, and electrically transferring the targeting vector plasmid containing PRSS1 gene into mouse embryonic stem cells to obtain the mouse embryonic stem cells carrying recombinant PRSS1 gene; microinjecting the mouse embryonic stem cells carrying the recombinant PRSS1 gene into albino mouse blastocyst, transferring the injected blastocyst into a pseudopregnant female mouse uterus for future birth, and obtaining a chimeric mouse after transplantation; combining a male chimeric mouse with a chimeric rate of more than 50% with a wild C57BL/6J female mouse, breeding to generate a next generation mouse, and screening a mouse carrying a PRSS1 gene, namely a mouse model simulating human acute pancreatitis; the nucleotide sequence of the targeting vector plasmid containing the PRSS1 gene is shown as SEQ ID NO. 1.
CN201710553062.9A 2017-07-07 2017-07-07 Construction method of mouse model for human acute pancreatitis Active CN107287236B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710553062.9A CN107287236B (en) 2017-07-07 2017-07-07 Construction method of mouse model for human acute pancreatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710553062.9A CN107287236B (en) 2017-07-07 2017-07-07 Construction method of mouse model for human acute pancreatitis

Publications (2)

Publication Number Publication Date
CN107287236A CN107287236A (en) 2017-10-24
CN107287236B true CN107287236B (en) 2020-12-01

Family

ID=60100101

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710553062.9A Active CN107287236B (en) 2017-07-07 2017-07-07 Construction method of mouse model for human acute pancreatitis

Country Status (1)

Country Link
CN (1) CN107287236B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2668201C1 (en) * 2017-12-08 2018-09-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный аграрный университет" Method for mimicking acute destructive pancreatitis in pigs
CN110551691A (en) * 2018-05-31 2019-12-10 华中科技大学 construction of idiopathic basal ganglia calcification pathogenic gene mutation mouse model
CN112029798B (en) * 2020-08-18 2021-12-24 桂林医学院附属医院 Construction method of mouse model for specifically expressing PIK3C 3S 282A in pancreatic acinar cells

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104146993A (en) * 2014-09-05 2014-11-19 戴睿武 Method for constructing rat high-triglyceride acute pancreatitis model
WO2015120069A1 (en) * 2014-02-04 2015-08-13 Beth Israel Deaconess Medical Center, Inc. Methods and kits for the diagnosis and treatment of pancreatic cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015120069A1 (en) * 2014-02-04 2015-08-13 Beth Israel Deaconess Medical Center, Inc. Methods and kits for the diagnosis and treatment of pancreatic cancer
CN104146993A (en) * 2014-09-05 2014-11-19 戴睿武 Method for constructing rat high-triglyceride acute pancreatitis model

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Acute Pancreatitis Animal Models and Recent Advances in Basic Research;Yuk Cheung Chan等;《Pancreas》;20070131;第34卷;1-14 *
Relationship of strain-dependent susceptibility to experimentally induced acute pancreatitis with regulation of Prss1 and Spink3 expression;Jun Wang等;《Laboratory Investigation》;20100215;第90卷;654–664 *
一种新的小鼠急性胰腺炎动物模型;贺志军等;《中国普通外科杂志》;20040930(第09期);661-663 *
不同剂量雨蛙素诱导小鼠急性胰腺炎模型的对比研究;周英等;《现代生物医学进展》;20161220(第35期);6804-6807 *
腹腔内注射L-精氨酸诱导法建立急性胰腺炎小鼠模型的评价;魏国丽等;《中国实验诊断学》;20111025(第10期);1631-1634 *

Also Published As

Publication number Publication date
CN107287236A (en) 2017-10-24

Similar Documents

Publication Publication Date Title
KR20210149060A (en) RNA-induced DNA integration using TN7-like transposons
CN104704110B (en) For treating the method and composition of heredity symptom
KR20200097760A (en) CPF1-related method and composition for gene editing
KR101999410B1 (en) Chromosomal landing pads and related uses
CN111733183B (en) Targeting vector for constructing liver injury mouse model, nucleic acid composition and construction method
BRPI0806354A2 (en) transgender oilseeds, seeds, oils, food or food analogues, medicinal food products or medicinal food analogues, pharmaceuticals, beverage formulas for babies, nutritional supplements, pet food, aquaculture feed, animal feed, whole seed products , mixed oil products, partially processed products, by-products and by-products
AU2016343979A1 (en) Delivery of central nervous system targeting polynucleotides
KR20140113997A (en) Genetic switches for butanol production
CN107287236B (en) Construction method of mouse model for human acute pancreatitis
CN108474034A (en) The method and its apparatus of gender determination are carried out to not hatching the avian embryonic in ovum
SG178735A1 (en) High throughput screening of genetically modified photosynthetic organisms
KR20190013627A (en) Yeast Strains and Methods for controlling hydroxylation of recombinant collagen
CN109929875B (en) Construction method and application of LAG3 gene humanized animal model
JP2023104002A (en) Exon-humanized mouse
RU2744831C2 (en) Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception
Kang et al. Apancreatic pigs cloned using Pdx1-disrupted fibroblasts created via TALEN-mediated mutagenesis
KR100552634B1 (en) Porcine uroplakin ? promoter and the production method of useful proteins using said promoter
CN106978416A (en) A kind of assignment of genes gene mapping integrant expression system and its application
CN114958760B (en) Gene editing technology for constructing Alzheimer disease model pig and application thereof
CN112280800B (en) Construct and application thereof in preparation of medicines for tracing and removing aged cells of animals
CN112969367B (en) Complement factor H gene knockout rat as C3 glomerulopathy model
CN114958759A (en) Construction method and application of amyotrophic lateral sclerosis model pig
KR20210150807A (en) Animal model for transplanting human hepatocytes and a method for screening anti-viral agent by using the animal model
CN115322993B (en) Safety site for site-directed integration of exogenous genes in pig genome and method for constructing pig breeding group by using safety site
CN111979265B (en) Construction method of spontaneous squamous cell lung carcinoma mouse model

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant